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ABSTRACT 
 Anorexia nervosa (AN) is a common disorder affecting the adolescent female 
population. In order to investigate the structure and function of the cardiovascular system 
in adolescents with AN, we performed case-control studies using echocardiography at rest 
to assess cardiac dimensions, systolic ventricular function, diastolic ventricular function, 
and vascular stiffness as well as echocardiography during exercise to investigate cardiac 
responses to hemodynamic stress. We found that female adolescents with AN have 
decreased left ventricular (LV) dimensions, LV wall thickness, LV mass, and 
abnormalities of diastolic ventricular function when compared to controls. Our patients 
demonstrated increased pulse wave velocity of the aorta, indicating increased aortic 
stiffness and potential increased future cardiovascular risk. During exercise, patients with 
AN demonstrated normal patterns of cardiovascular response with progressive exercise, 
although cardiac responses at peak exercise were decreased compared to controls. These 
findings demonstrate abnormalities in cardiac and vascular structure and function in 
adolescent females with AN.  
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Chapter 1: Introduction, Overview, and Literature Review 
Introduction 
Anorexia nervosa (AN) is an eating disorder characterized by a restriction of 
energy intake, low body weight, fear of gaining weight, and a distorted body image [1]. 
AN has an approximate lifetime prevalence between 1-4% and carries the highest 
mortality rate of any other psychiatric disorder [2].  This disorder is most commonly 
diagnosed in females with a peak incidence between 15-19 years [2]. The diagnosis is 
based on meeting the criteria outlined in the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition, text revision (DSM-IV-TR) which includes: 
1. Refusal to maintain body weight at or above a minimally normal weight for 
age and height: Weight loss leading to maintenance of body weight <85% of 
that expected or failure to make expected weight gain during period of growth, 
leading to body weight less than 85% of that expected. 
2. Intense fear of gaining weight or becoming fat, even though under weight. 
3. Disturbance in the way one's body weight or shape are experienced, undue 
influence of body weight or shape on self evaluation, or denial of the 
seriousness of the current low body weight. 
4. Amenorrhea (at least three consecutive cycles) in postmenarchal girls and 
women. Amenorrhea is defined as periods occurring only following hormone 
(e.g., estrogen) administration [3].  
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AN has effects on multiple organ systems secondary to the patient being in a state 
of starvation. Cardiac involvement is among the most common complications of AN and 
affects almost 80% of patients [4]. Electrophysiologic abnormalities seen in AN include 
prolongation of the QT interval and increased QT dispersion, bradycardia, first degree 
heart block, premature ventricular contractions, and other arrhythmias [5-8]. AN has been 
associated with structural, echocardiographic, and functional cardiac anomalies including 
decreased cardiac mass, mitral valve prolapse, pericardial effusions, reduced left 
ventricular (LV) dimensions, and decreased cardiac output (CO) [5, 9-11]. Cardiac 
complications, particularly abnormalities of the QT interval, contribute to the risk of 
sudden death in patients with AN [5, 8].  
In addition to the risk of sudden death, it has also been suggested in the literature 
that patients with AN may be predisposed to future cardiovascular (CV) risk [12-14]. 
Arterial stiffness is being increasingly recognized as a marker of risk for future CV 
events, including stroke and myocardial infarction (MI), in both healthy and diseased 
populations [15-17]. Pulse wave velocity (PWV) is a validated measure of arterial 
stiffness and is defined as the speed of travel of the pressure pulse along an arterial 
segment [17, 18]. Increased arterial stiffness creates a faster propagation of the pressure 
pulse which causes PWV to increase. PWV is an independent, early, and sensitive 
predictor of CV risk and can be calculated using Doppler echocardiography [15-17, 19, 
20]. Arterial stiffness as a marker for vascular health and CV risk in AN has not been 
previously studied.  
Despite seemingly normal cardiac function in the resting state, physiological 
stresses can unmask cardiac dysfunction. One common method of unmasking cardiac 
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pathology is to assess patients during the hemodynamic stress of cardiopulmonary 
exercise. A few studies in patients with AN have suggested possible subclinical cardiac 
dysfunction, however, further investigation in order to determine if exercise can unmask 
echocardiographic ventricular dysfunction has not been previously performed in this 
population [21, 22]. Although patients with AN have been shown to have decreased 
exercise endurance, decreased maximal oxygen uptake (VO2), and blunted heart rate 
(HR) and blood pressure (BP) response to exercise, assessment of cardiac responses to 
incremental exercise is limited [23-26].  
 
Purpose of the Study: 
 The purpose of our study was to assess the cardiovascular system and its function 
in adolescent females with AN. We began by performing a complete echocardiographic 
study at rest in patients and controls in order to characterize the echocardiographic 
parameters of left atrial (LA) and LV cardiac dimensions, systolic ventricular function, 
and diastolic ventricular function at rest in adolescent females with AN. To measure their 
vascular health and the potential for future CV risk, we characterized the biophysical 
properties of the aorta, including the PWV, using Doppler echocardiography. Finally, in 
order to try to unmask subtle changes in cardiac function in adolescent females with AN, 
we assessed their exercise capacity and echocardiographic ventricular function during 
exercise, as this represents a state of hemodynamic stress. The goal of our research was to 
comprehensively assess the cardiovascular health of this patient population.  
 
Thesis Presentation Format: 
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 The following thesis will be presented in manuscript format. It consists of three 
manuscripts which will divide the content into echocardiographic abnormalities at rest, 
the biophysical properties of the aorta, and exercise capacity and echocardiographic 
ventricular function during exercise in adolescent females with AN. 
 
Literature Review: 
Structural, functional, and echocardiographic abnormalities in AN 
 Studies regarding cardiac abnormalities in AN have looked at several structural, 
functional, and echocardiographic abnormalities in young women with this disorder. 
These studies are described below. For ease of interpretation, the cardiac abnormalities 
described in the studies below are summarized in Appendix 1. 
 St John Sutton et al. (1985) studied 17 females with AN (mean age of 26) and 
compared them to 10 normal weight controls [26]. They showed a decreased systolic 
blood pressure (sBP) and diastolic blood pressure (dBP) in the AN group as compared to 
controls, but no difference in resting HR [26]. LV end-diastolic diameter (LVEDD), LV 
end-systolic diameter (LVESD), LV posterior wall diameter (LVPWD), end-diastolic and 
end-systolic volume indexes, LV mass (LVM), and LV mass indexed (LVMI) were 
decreased in the AN group as compared to controls [26]. There were no changes in the 
LV chamber shape, the end-diastolic relative wall thickness, or the LV mass-to-volume 
ratio, indicating a normal LV architecture [26]. End-systolic meridonal and 
circumferential wall stresses, fractional shortening (FS), ejection fraction (EF), and 
velocity of circumferential fiber shortening (MVCFc) showed no difference between 
groups, indicating normal LV afterload and systolic ventricular function at rest [26]. 
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De Simone et al. (1994) studied 21 white women with AN with a mean age of 22 
years [9]. The control groups consisted of 19 normal weight women (BMI 20-27.3) and 
22 constitutionally thin women (BMI <20) [9]. The constitutionally thin control group did 
not meet criteria for AN and had normal scores on a food questionnaire [9]. When 
compared to normal weight and constitutionally thin women, the AN group were found to 
have lower HR, sBP, and dBP [9]. The incidence of mitral valve motion abnormalities 
was higher in women with AN, but this was not functionally significant as there was no 
important mitral regurgitation in any of the groups [9]. LVEDD and LVM were smaller in 
the AN group than controls and these differences persisted after indexing for height and 
controlling for body weight, height, BP, and HR [9]. The authors believed that LV mass 
was decreased due to both a reduction in afterload and preload of the LV [9].  LV relative 
wall thickness was elevated in the AN group after controlling for height and weight [9].  
There were no changes in end-systolic stress or FS, although the percent predicted FS was 
decreased in AN patients, which the authors felt may indicate mild LV dysfunction [9]. 
CO and cardiac index (CI) were lower in AN patients [9]. Systemic vascular resistance 
(SVR) was increased in AN. Women with AN had a smaller LA diameter [9]. There were 
no differences between groups in the transmitral peak E wave velocity (which represents 
early diastolic LV filling), however, the AN group had a significantly smaller peak A 
wave velocity (which represents the contribution of atrial contraction to LV filling in late 
diastole) and increased E/A ratio [9]. These abnormalities were reported to indicate 
impaired LV filling [9].  
 Romano et al. (2004) studied 91 young females with AN with a mean age of 20.5 
years compared to 62 normal weight controls [11].  Their results were very similar to 
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those of de Simone et al. (1994), including females with AN having statistically 
significant decreases in HR, LVEDD, LVM, LVMI, stroke volume (SV), and CO as well 
as increased SVR [9, 11]. Their results differed from those of de Simone et al. (1994) in 
terms of cardiac contractility as they found a statistically significant decrease in EF in 
women with AN as compared to controls [9, 11]. Additionally, Romano et al. (2004) 
found that stroke work and the percent predicted LVM were significantly decreased in the 
AN group [11]. Their results showed that a greater percentage of subjects in the AN 
group (19 vs 5%) had an inadequate LVM when compared to the control group [11]. The 
authors concluded that AN is a condition of low hemodynamic load giving cardiac 
hypotrophy [11].  
 Vazquez et al. (2003) studied 30 adolescent females with AN and compared them 
to 30 age matched controls of normal weight [4]. The authors found that the AN group 
had decreased HR and LV dimensions including  decreased LVEDD, LVESD, 
interventricular septum diameter (IVSD), LVM, and LVMI [4]. There were no 
differences in LVPWD or in LV function as measured by FS and EF [4].  
 Eidem et al. (2001) retrospectively studied 13 adolescents with AN and used 13 
normal weight pediatric controls for comparison [21]. They investigated the use of the 
myocardial performance index (MPI), which is a ratio of isovolumic contraction time and 
isovolumic relaxation time (IVRT) to ejection time. The MPI is used as a measure of 
global ventricular performance including both systolic and diastolic function [21]. Similar 
to the previous studies, LVM was found to be decreased. Similar to de Simone et al. 
(1994) and Vazquez et al. (2003), there was no difference in clinical systolic ventricular 
function [4, 9, 21]. No difference between groups was seen in diastolic function using the 
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usual measurements of mitral E/A ratio and deceleration time, which is in contrast to the 
study by de Simone et al. (1994) in which the AN group had an elevated E/A ratio [9, 
21]. Despite not finding differences between groups in the variables commonly used 
clinically to assess systolic and diastolic function, the AN group has a significantly 
elevated LV MPI as compared to controls, indicating worsened ventricular function [21]. 
There was no difference in the right ventricular (RV) MPI [21]. This study concluded that 
the increase in MPI suggests subclinical LV dysfunction in their population of adolescent 
females with AN [21].  
 Galetta et al. (2003) studied 25 females with AN compared to 25 age matched 
controls of normal weight (BMI >20 kg/m2) and 25 thin females (BMI <20 kg/m2) 
without AN [27]. Their results agreed with the above studies in showing that the AN 
group had a decreased HR, BP, LVEDD, LVESD, LVM, LVMI, FS, EF, and mitral valve 
peak A velocity with an increased mitral valve E/A ratio and no difference in the mitral 
valve peak E velocity [27]. The findings for the mitral valve peak E velocity, peak A 
velocity, and E/A ratio indicated abnormal LV diastolic filling and were comparable to 
those reported by de Simone et al. (1994) [9, 27]. They additionally investigated the 
IVRT, which is also an indicator of diastolic function, and found no differences between 
groups [27]. They demonstrated no difference in IVSD, in contrast to Vazquez et al. 
(2003), and no difference in LVPWD [4, 27]. 
 In a later study, Galetta et al. (2005) investigated 20 young females with AN 
compared to 20 thin and 20 normal weight controls as in their previous study [22]. They 
showed the same differences between the AN and control groups as seen in their previous 
study, with the exception of showing a decrease in the IVSD and LVPWD in the AN 
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group which was not demonstrated in the previous study [22]. They additionally studied 
tissue Doppler imaging in AN as an early marker of cardiac dysfunction by looking at the 
myocardial systolic wave (S’), the early diastolic wave (E’), and the diastolic wave during 
atrial contraction (A’) [22]. The AN group had a lower S’ peak in the lateral LV wall and 
interventricular septum (IVS), indicating impaired systolic LV function [22]. The peak S’ 
correlated with LVM [22]. There was no difference in the peak E’, A’, or E’/A’ ratio, 
indicating that the LV diastolic function, as measured by tissue Doppler, was not 
impaired [22]. 
 The largest study of echocardiographic abnormalities in adolescent females with 
AN was performed by Kastner et al. (2012), although they investigated fewer 
echocardiographic parameters than the majority of previous studies [28]. They studied 
173 adolescent females with AN compared to 41 normal weight controls [28]. Similar to 
the previous studies, they showed decreased LVEDD and LVESD in the AN group and 
no difference in FS, IVSD, or LVPWD [28]. They also showed an increased incidence of 
pericardial effusions in the AN group (34.7% vs 0%) although these were all small to 
moderate in size and were clinically silent [28]. There were no risk factors to predict the 
occurrence of an effusion in the AN group [28].  
 A cross-sectional study by DiVasta et al. (2010) compared 38 female adolescents 
and young women who were admitted for medical complications of AN to published 
normal values [29]. They found that approximately 1/3 of patients with AN had a lower 
than predicted LVMI, LVPWD, and IVSD [29]. LV end-systolic stress was lower than 
average in 70% of subjects and MVCFc was better than predicted. The EF and FS for the 
AN subjects was within normal limits [29].  
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Several studies have also demonstrated reversibility of echocardiographic changes 
with weight restoration in AN. St John Sutton et al. (1985) found increases in LVMI and 
LV end-diastolic volume indexed after weight gain, but no change in FS, EF, and wall 
stress [26]. Mont et al. (2003) looked at 31 patients with AN (80% female) and showed a 
significant increase in HR, LVEDD, LVESD, LA size, LVM, LVMI, CO, CI, transmitral 
A wave velocity, and transmitral E wave velocity with weight restoration [30]. There 
were no significant changes with weight restoration in IVSD, LVPWD, EF, mitral 
deceleration time, E/A ratio, or IVRT [30]. Olivares et al. (2005) studied 40 adolescent 
females with AN compared to 40 normal weight controls [10]. They found improvements 
in HR, LVEDD, LVESD, LVM, LVMI, and CO with weight restoration [10]. There were 
no changes in LVPWD, IVSD, FS, or EF [10]. Mitral valve prolapse was found in 8 
patients in the AN group (of no hemodynamic significance) and persisted in 3 after 
weight restoration [10]. Ulger et al. (2006) investigated 11 adolescent females with AN 
and showed that 1 year after refeeding, there was recovery of HR, sBP, dBP, LVEDD, 
IVSD, LVPWD, LVM, and LVMI [31]. Kastner et al. (2012) demonstrated an 
improvement in LVESD with weight restoration, however there was no improvement in 
LVEDD as was demonstrated in prior studies [28]. Kastner et al. (2012) also showed no 
change in IVSD, LVPWD, or FS [28]. DiVasta et al. (2010) had follow-up 
echocardiographic data on 17 subjects with AN and showed decreased IVSD, decreased 
MVCFc, and no change in absolute LVM with weight restoration, which is in contrast to 
previous studies [29]. Overall, the majority of studies show that the many of functional 
and echocardiographic abnormalities in patients with AN are reversible with weight 
restoration. 
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 In summary, echocardiographic structural and functional cardiac abnormalities 
including mitral valve prolapse, pericardial effusions, reduced LV dimensions, decreased 
cardiac mass, and decreased CO have been well documented in the literature. The 
majority of studies suggest that systolic ventricular function as assessed by the 
conventional echocardiographic measures of EF and FS is normal in patients with AN, 
although studies using tissue Doppler and the MPI suggest that subclinical cardiac 
dysfunction may be present in this patient population. There is disagreement on the 
presence of diastolic ventricular function in AN as transmitral velocities have 
demonstrated abnormalities, while other measures of diastolic function have not shown 
differences. Many of the demonstrated cardiac abnormalities in AN have been shown to 
be at least partially reversible with nutritional rehabilitation. The majority of studies 
performed have been in adult populations and have investigated small numbers of 
patients.  
 
Future Cardiovascular Risk in AN 
 Although women with AN are at increased risk of sudden death related to suicide 
and arrhythmias, they may also be at risk of atherosclerotic CV disease with increasing 
age [13, 14]. Several studies have documented the presence of biomarkers which are 
associated with increased future CV risk in females with AN. However, whether or not 
these risk factors which are associated with MI and stroke in other populations also confer 
increased risk in AN is unknown. One such risk factor is dyslipoproteinemia, which is a 
known risk factor in other populations for future CV events including MI and stroke. 
Elevation in total serum cholesterol, low-density lipoprotein (LDL), and triglycerides 
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(TG) as well as a decrease in high density lipoprotein (HDL) are associated with an 
increase in CV risk. Apolipoprotein B (ApoB) is a structural protein of LDL, with high 
levels of ApoB indicating increased CV risk [32]. Apolipoprotein A1 (ApoA1) is a 
structural protein of HDL, with high ApoA1 being protective of CV events [32]. Other 
reported risk factors for CV disease are inflammatory markers including elevated levels 
of high sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) [33]. The 
following paragraphs will summarize the current literature on biomarkers associated with 
CV risk in the presence of AN.  
The presence of elevated cholesterol levels in patients with AN was first 
documented by Klinefelter in 1965 [34, 35]. Since that time, multiple recent studies have 
confirmed the finding of hypercholesterolemia, with more variable results for LDL and 
HDL levels. Case et al. (1999) examined 9 young adult females with AN of the binge-
purge subtype and found elevated total cholesterol, LDL, apoB, apoA1, triglycerides 
(TG), and intermediate-density lipoprotein-apoB levels compared to 10 controls [36].  
Boland et al. (2001) studied 101 females with AN and found increased total and LDL 
cholesterol levels with no difference in HDL or TG as compared to 95 age matched 
controls [37].  Zak et al. (2005) compared 16 women with AN to 25 healthy controls and 
documented increased levels of total cholesterol, TG, and HDL [38]. Ohwada and 
colleagues (2006) found elevated total cholesterol, LDL, HDL, ApoA1, and ApoB in 39 
women with AN as compared to 24 controls [35]. Rigaud et al. (2009) studied 120 adult 
women with AN compared to 120 healthy women and found elevated total cholesterol 
(which was higher in the AN binge-purge subtype than in the restrictive AN subtype), 
LDL, HDL, ApoA1, ApoB, and TG [39].  Matzkin and colleagues found in 2 separate 
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studies that total cholesterol and LDL were elevated in women with AN [40, 41]. Nova et 
al. (2007) studied 14 women with AN and found elevated total cholesterol and LDL, 
decreased HDL, and no difference in TG [42]. There remains, however, some controversy 
in the literature with some reports of normal cholesterol levels in AN. Arden et al. (1990) 
studied 16 females with AN compared to 16 athletic normal weight controls, and found 
no difference in cholesterol values or LDL at diagnosis, but the authors acknowledge that 
the study may have been underpowered to detect a difference in cholesterol values 
between groups [43].  
Fewer studies have been performed investigating inflammatory and ultrasound 
markers associated with CV risk in AN. Lawson et al. (2007) studied 181 women with 
AN compared to 41 healthy controls [12]. Women with AN had lower hsCRP levels than 
healthy controls, however, 20% of women with AN and on oral contraceptive pills had 
high-risk hsCRP levels, which may place this subset of women at increased CV risk [12]. 
Birmingham et al. (2003) investigated the intima-medial thickness of the carotid artery 
using ultrasound, which is a surrogate measure of coronary atherosclerosis, in 18 women 
with AN compared to an unspecified number of age-matched controls [44]. There was no 
difference in the intima-medial thickness of the carotid artery between the groups [44].  
The majority of the studies listed above have been performed on adult women 
with AN. There are few reports on biomarkers associated with future CV risk in 
adolescents with AN. Misra et al. (2006) studied 23 adolescent girls with AN and 
compared them to 20 healthy adolescent female controls [13]. Girls with AN had lower 
TG, increased HDL, and unchanged total and LDL cholesterol levels as compared to 
controls [13]. They also found increased Apo-B and IL-6 levels but decreased hsCRP 
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[13]. The only change in these biomarkers with weight gain was a decrease in the IL-6 
levels [13]. These authors reported an uncoupling of CV risk factors in this adolescent 
cohort, with the decreased hsCRP, low TG, and elevated HDL levels suggesting 
decreased CV risk whereas the increased IL-6, ApoB, and ratios of ApoB/HDL and 
ApoB/LDL indicate increased CV risk [13]. 
 Although the actual risk of MI and the contribution of the above mentioned risk 
factors in identifying women with AN with risk of future CV events is unknown, there are 
reports of MI in young women with AN. Garcia-Rubira et al. (1994) reported a case of a 
39 year old woman with AN since the age of 17 who developed an inferior MI during 
hyperalimentation therapy [45]. Abuzeid and Glover (2011) reported a case of a 39 year 
old woman with AN since the age of 13 who presented with an acute anterior wall MI 
with 100% occlusion of the proximal left anterior descending coronary artery [46]. 
Rigaud et al. (2012) reported 2 cases of MI in their study of 41 severely malnourished 
AN patients [47]. The clinical characteristics of these 2 cases were not described; 
however, the oldest that these women could have been was 45 years as this was the 
maximum age of the cohort [47]. Rigaud et al. (2009) also reported 2 cases of MI in 
women with AN aged 37 and 41 years, although it is unclear if these are the same patients 
reported in the Rigaud et al. (2012) study [39, 47]. The incidence of MI in patients with 
AN is unknown and it is likely that fatal cases of MI are likely under-recognized in the 
setting of AN. Although studies specifically regarding atherosclerotic risk in AN have not 
been performed, these cases of premature MI in women with AN raise the possibility that 
AN may be associated with increased atherosclerotic CV risk.  
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The majority of published studies demonstrate an improvement in dyslipidemia 
with weight restoration. Ohwada et al. (2006) showed decreases or normalization in total 
cholesterol, TG, HDL, and LDL with weight gain [35]. Rigaud and colleagues (2009) 
demonstrated that 95% of the AN patients who achieved a normal BMI had normalization 
of all lipoprotein levels [39]. Jauregui-Garrido et al. (2012) studied 102 women with AN 
and showed a decrease in total cholesterol, LDL, TG, LDL/HDL ratio, and total 
cholesterol/HDL and an increase in HDL with weight restoration [48].  Some studies, 
however, have shown persistence of dyslipoproteinemia despite weight restoration. Arden 
et al. (1990) demonstrated that HDL and ApoA1 increased with weight restoration, 
however, ApoB remained elevated [43].  Nova et al (2007) showed no difference in total 
cholesterol, LDL, or TG with weight gain, although there was an increase in the HDL 
level [42].  
 In summary, females with AN may be at risk for CV disease in the future as 
indicated by case reports of MI in young women with AN, and the presence of 
biomarkers associated with CV risk including dyslipidemia and elevated IL-6 and hsCRP. 
However, there remains controversy in the literature as some studies report an absence of 
known risk factors for atherosclerotic disease in the AN population, which may be related 
to these studies being underpowered to detect differences between groups. The effect of 
weight restoration on these risk factors is unclear as there is also controversy in the 
literature regarding the effect of nutritional rehabilitation on cholesterol and lipoproteins. 
As well, there is no literature on the effect of weight restoration in AN on the 
inflammatory markers associated with CV risk. Further study to determine the risk of 
atherosclerotic CV disease in patients with AN is necessary.  
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Arterial stiffness, pulse wave velocity, and future cardiovascular risk 
 Large arteries are distensible structures which play a critical role in 
accommodating the SV during ventricular systole and providing adequate distribution of 
blood flow during diastole [18]. One of the earliest detectable manifestations of adverse 
structural and functional changes in the vessel wall is arterial stiffness [18]. Increased 
arterial stiffness is associated with CV risk including coronary artery disease and stroke 
[15, 18]. 
The most validated method of noninvasively measuring arterial stiffness is using 
pulse wave velocity (PWV) [18]. PWV is calculated by measuring the transit time of the 
pressure pulse at 2 different points in a vascular segment, and dividing the distance 
travelled by the transit time.  PWV is inversely related to vascular compliance, such that a 
stiffer vessel will result in an elevated PWV. It is an accurate, simple, and reproducible 
measurement and is considered the gold standard index of arterial stiffness [18, 49-51].  
PWV has been shown in many studies to be an independent predictor of coronary artery 
disease and stroke in healthy adults and in adults with diseases known to be associated 
with CV risk [18]. Mattace-Raso et al. (2006) studied 2835 apparently healthy subjects as 
part of the Rotterdam Study [15]. They found that the risk of coronary heart disease 
increased with increasing aortic PWV and that PWV was an independent predictor of 
coronary heart disease and stroke [15]. PWV has also been associated with increased fatal 
stroke, all-cause mortality, and CV mortality in hypertensive adults [52, 53]. Mitchell et 
al. (2010) reported that increased PWV in subjects of the Framingham Heart Study was 
associated with increased risk for a first CV event, which consisted of MI, unstable 
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angina, heart failure, or stroke [54]. Cruickshank et al. (2002) found that in adults with 
diabetes and impaired glucose tolerance, PWV was an independent predictor of all cause 
and CV mortality [55]. 
Pulse wave velocity has also been studied in pediatric populations. Despite their 
younger age, pediatric patients with disease states thought to be associated with increased 
arterial stiffness have shown abnormalities in aortic PWV. Sandor et al. (2003) 
demonstrated elevated PWV in children with Marfan syndrome and inflammatory 
connective tissue disease, with the results in Marfan syndrome being confirmed in a 
larger study by Bradley et al. (2005) [56, 57]. Bradley et al. (2010) demonstrated elevated 
PWV in children aged 8-13 with a history of being born small for gestational age [58]. 
Harris et al. (2012) demonstrated increased PWV in obese children as compared to 
controls [59]. Al Huzaimi et al. (2013) demonstrated increased PWV in children with a 
history of Kawasaki disease as compared to controls [60].  There have been no studies 
assessing arterial stiffness or PWV in either adolescents or adult patients with AN as a 
predictor of potential future CV risk. 
In summary, arterial stiffness is one of the earliest manifestations of vascular 
disease and is associated with increased CV risk. PWV is the most validated method of 
measuring arterial stiffness and has been shown in many studies to be associated with the 
risk of CV events. PWV has been assessed in many adult and pediatric populations, 
however, there is no literature regarding arterial stiffness in patients with AN despite 
suggestions that these patients may be at increased risk for future CV disease.  
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Exercise Capacity and Cardiac Function During Exercise in Anorexia Nervosa 
 Exercise places physiologic stresses on the body and hemodynamic stresses on the 
heart. As many patients with AN have abnormalities in cardiac size and structure, it is 
conceivable that maladaptive responses to exercise and the associated hemodynamic 
stresses may occur in this population. Many adolescent patients with AN exercise 
excessively during the acute phase of the disorder, with rates as high as 80% being 
reported in the literature [61]. In addition, adequately dosed exercise may be beneficial 
for patients with AN, although there remains controversy regarding the role of exercise in 
AN treatment [62-65]. As such, it is important to determine how the CV system responds 
to exercise in AN.  
Subnormal exercise tolerance, maximal oxygen uptake (VO2), HR response, and 
BP response during exercise in patients with AN have been reported in the literature. 
Fohlin (1977) studied 31 adolescents (19 girls and 12 boys) with AN and found a blunted 
maximal HR response and decreased VO2 out for proportion to the decrease in body 
weight [66]. Fohlin et al. (1978) studied 17 female and 11 male adolescent patients with 
AN and found a blunted peak HR response and decreased VO2 [67]. Gottdiener et al. 
(1978) studied 11 adult females with AN with a treadmill exercise test and found 
subnormal BP and HR responses to exercise [23]. Davies et al. (1978) studied 15 
adolescents (5 boys and 10 girls) with AN and found that VO2 was decreased 20-40% 
below normal in the female AN patients, which was greater than could be attributed to 
their change in body size and composition [68]. St John Sutton et al. (1985) performed 
exercise testing in 17 females with AN and found decreased exercise duration, blunted 
HR and BP responses, and decreased VO2 [26]. Roche et al. (2004) investigated 14 
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patients with AN and 8 patients with significant weight loss but not meeting criteria for 
AN [25]. Exercise testing was performed using a cycle ergometer, which demonstrated 
chronotropic incompetence in 59% of all subjects, and this group had a lower BMI than 
patients without chronotropic incompetence [25]. AN patients with a lower BMI had 
more severe limitation to maximal exercise, lower peak HR, and lower peak VO2 [25]. 
They also found that BMI correlated to peak VO2 and maximal HR [25]. 
Nudel et al. (1984) compared 20 adolescent patients with AN to 15 controls using 
bicycle exercise testing [24].  The AN patients had decreased HR, sBP, VO2, plasma 
norepinephrine, and plasma dopamine levels [24]. Twenty-five percent of the patients 
developed significant ST depression with exercise, which may represent myocardial 
dysfunction with exercise [24]. These authors concluded that patients with AN have 
abnormal working capacity, CV response, and sympathetic responses to exercise [24]. 
They also theorized that part of the blunted HR and BP response was related to a 
decreased sympathetic response, as evidenced by lower norepinephrine levels [24].  
Lands et al. (1992) examined 9 adolescent girls with AN and 10 adolescent controls 
during progressive and steady-state exercise using a cycle ergometer [69]. Subjects with 
AN performed less work than expected, with the maximum work achieved correlating 
with BMI percentile [69]. Cardiac output measured by the indirect (CO2 rebreathing) Fick 
method was comparable between AN patients and controls [69]. The normalized CO was 
achieved in the AN patients by a high HR compensating for a low SV [69]. However, the 
result of a high HR in AN patients is surprising as the majority of studies suggest a 
blunted HR response in this group of patients. They concluded that exercise capacity in 
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AN is limited by diminished muscle mass or muscular dysfunction rather than by a 
diminished cardiac or ventilatory response [69].   
Studies of echocardiographic function during exercise in patients with AN has 
been limited. Rowland et al. (2003) studied 8 adolescent females with AN compared to 
24 healthy controls using upright cycle exercise and Doppler measurement of aortic 
diameter and aortic flow from the suprasternal notch to determine the SV, peak aortic 
velocity, and CO [70]. Patients with AN had decreased resting and maximal HR [70]. 
Maximal relative VO2 was lower in patients than controls, indicating decreased aerobic 
fitness [70]. They demonstrated increased SV index in patients compared to controls, with 
a normal pattern of increase in SV index with progressive exercise [70]. There was no 
difference in maximal CI between groups, as the increased SV compensated for the 
decreased HR in AN patients, which is opposite to what was found Lands et al. (1992) 
[69, 70]. There were no dysrhythmias during testing, although one patient demonstrated 
“scooping” of the ST segment with exercise [70]. They concluded that aerobic fitness was 
lower in patients with AN but there was no evidence of abnormal myocardial 
performance since SV, peak aortic velocity, and rate of acceleration of blood flow 
continued to increase with progressive exercise [70]. Of note, the control subjects were 
younger than the patients in this study, which may have affected the results the study.  
The effects of weight restoration on exercise performance in patients with AN has 
also been investigated. Fohlin (1978) studied 3 male and 5 female adolescents with AN 
after refeeding and found an increase in maximal HR response and maximal VO2 [71]. 
Rigaud et al. (1997) studied 15 patients with AN compared to 15 normal weight controls 
with serial upright bicycle exercise testing during refeeding [72]. Prior to weight 
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restoration, AN patients had a 49% lower workload reached with exercise [72]. The 
workload reached correlated with body weight, fat-free mass, and leg circumference [72]. 
After refeeding, the workload reached improved to normal values in the AN patients 
despite VO2 and body weight remaining decreased from normal after 45 days of 
nutritional rehabilitation [72]. They concluded that muscle performance was restored by 
refeeding and this occurs before normal nutritional status is achieved [72]. Waller et al. 
(1996) studied 10 patients with AN using cycle ergometry and found that VO2 increased 
linearly with increases in body weight [73]. Mont et al. (2003) studied 31 patients with 
AN before and after weight restoration using Bruce protocol treadmill exercise testing 
[30]. They found increases in exercise duration, maximal HR, and workload after weight 
restoration [30]. DiVasta et al. (2010) studied 38 females with AN after nutritional 
rehabilitation using Bruce protocol treadmill exercise testing [29]. They concluded that 
the exercise test was normal, however did not state what criteria this was based on [29]. 
They found no relation between the degree nor amount of pre-admission exercise and the 
stress test performance [29].   
Overall these studies demonstrate that patients with AN have decreased exercise 
tolerance, peak HR, peak BP, and peak VO2. Limited echocardiographic data during 
exercise suggests normal SV and CO responses to progressive exercise, although ST 
changes with exercise have been described. Weight restoration improves exercise 
endurance and VO2 as well as HR and BP response. Studies of exercise in adolescents 
with AN have been limited and have included small numbers of patients. As well, more 
detailed assessment of echocardiographic LV myocardial function with exercise has not 
been previously performed in this population.  
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Chapter 2: An Echocardiographic Study of Cardiac Size and Function 
in Adolescent Females with Anorexia Nervosa 
 
Abstract 
Background: Cardiac involvement occurs in the majority of patients with anorexia 
nervosa (AN), however, controversy still exists regarding systolic and diastolic function 
in females with AN. The purpose of our study was to investigate echocardiographic 
indices of cardiac dimensions, output, and systolic and diastolic function in adolescent 
females with AN. 
Methods: We performed a retrospective case-control study of adolescent females with 
AN compared to healthy adolescent controls. A complete echocardiogram including a 
detailed left ventricular (LV) function protocol was performed for controls and patients 
with AN during their acute phase of illness. LV dimensions, LV mass (LVM), LV mass 
indexed for body surface area (LVMI), left atrial (LA) size, stroke volume (SV), cardiac 
output (CO), and cardiac index (CI) were measured. LV systolic function was measured 
using fractional shortening (FS), mean velocity of circumferential fiber shortening 
(MVCFc), and systolic tissue Doppler imaging (TDI) at the LV lateral wall (LVlateral), 
interventricular septum (IVS), and right ventricular free wall (RV). Diastolic function was 
measured using transmitral E and A wave velocity, pulmonary venous velocities, and 
diastolic TDI E’ and A’ wave velocities. BMI percentiles were calculated for patients and 
controls and patients were divided into those of BMI ≤10th percentile (AN≤10th) and >10th 
percentile (AN>10th).  
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Results: We studied 95 adolescent AN patients (ANtotal) and 58 healthy adolescent female 
controls. There were 70 patients in the AN≤10th group. ANtotal and AN≤10
th groups had 
reduced LV dimensions, LA size, LVM, LVMI, SV, CO, and CI compared to controls, 
with no differences between AN>10th and controls. There were no differences between 
controls and all AN groups in FS, MVCFc, or systolic TDI. Pulmonary venous A wave 
velocity was significantly decreased in ANtotal and AN≤10
th as compared to controls with 
no difference in transmitral E or A wave velocity or E/A. LVlateral E’ and A’, IVS E’ and 
A’, and RV A’ were significantly decreased in ANtotal and AN≤10
th, with only a decrease 
in RV A’ in AN>10th as compared to controls.  
Conclusions:  Adolescent females with AN have downsized LV dimensions, LVMI, and 
CI, but systolic ventricular function remains preserved. Diastolic TDI is decreased in AN 
patients. Patients with BMI ≤10th percentile demonstrate changes in LV dimensions and 
diastolic function and warrant more careful monitoring.  
 
Introduction 
Anorexia nervosa (AN) carries one of the highest mortality rates of the psychiatric 
disorders, with cardiac complications contributing to the risk of sudden death in these 
patients [1-5].  Cardiac involvement, including both electrophysiologic and structural 
abnormalities, occurs in approximately 80% of patients with AN [2, 6, 7]. 
Echocardiographic structural and functional cardiac abnormalities including decreased 
cardiac mass, mitral valve prolapse, pericardial effusion, reduced left ventricular (LV) 
dimensions, and decreased cardiac output (CO) have been well documented in the 
literature [2, 6, 8-11].  
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Despite reduced LV dimensions and mass, ventricular systolic function at rest in 
females with AN, as measured by the standard echocardiographic indices of ejection 
fraction (EF) and fractional shortening (FS), has consistently been shown not to differ 
when compared to female controls [7-9, 11-14]. However, studies of systolic tissue 
Doppler indices and the myocardial performance index (MPI) have suggested that there 
may be subtle decreases in systolic function at rest in females with AN [12, 13]. Fewer 
studies have investigated diastolic function in AN, and there have also been conflicting 
results. While transmitral A wave velocities and E/A ratio have been shown to be 
different in patients with AN, other measures of diastolic function including tissue 
Doppler have not shown differences [8, 13, 14]. The majority of these studies have, 
however, been performed on relatively small numbers of patients and in adult populations 
[7, 8, 10-14]. 
The purpose of our study was to investigate echocardiographic indices of cardiac 
dimensions, output, and systolic and diastolic function in a large number of adolescent 
females with AN and to compare these parameters to control subjects. To our knowledge, 
this is one of the largest series of echocardiographic changes in adolescent females with 
AN that has been published in the literature and the largest tissue Doppler imaging (TDI) 
study in AN patients.  
 
Methods 
Subjects 
We retrospectively studied female adolescents with AN who were referred by the 
Eating Disorders Program for routine cardiac assessment at the Children’s Heart Centre at 
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the British Columbia Children’s Hospital between October 2003 and August 2010. The 
diagnosis of AN was made clinically by a multidisciplinary team including psychiatry and 
adolescent medicine and was based on the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV) criteria [15]. Patients were studied during the acute 
phase of presentation and treatment for AN and consisted of both hospitalized patients 
and those seen as outpatients. If patients had more than one assessment, only the data 
from the complete initial assessment were used. Patients with evidence of structural heart 
disease were excluded. The control group was composed of healthy female adolescents 
from our established healthy control Doppler echocardiography database.  The controls 
were of normal weight and did not have a history of AN. Control patients were volunteers 
recruited from friends and family of hospital employees. 
Echocardiographic data were recorded as well as height (cm), weight (kg), body 
mass index (BMI, kg/m2), body surface area (BSA, m2), heart rate (beats/min) and blood 
pressure (BP, mmHg) at the time of study. Ethics approval for this study was obtained 
from the Children’s and Women’s Hospitals’ Research Ethics Board and the University 
of British Columbia’s Clinical Research Ethics Board.  
 
Echocardiography 
All subjects underwent a complete echocardiogram by an experienced 
echocardiographer using our lab’s detailed LV function protocol. The examination was 
performed in the left lateral decubitus position.  
Measurements of LV dimensions and mass were performed. Standard assessment 
of LV internal diameters were measured at end-systole (LVESD) and end-diastole 
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(LVEDD) with the interventricular septal wall diameter (IVSD) and LV posterior wall 
diameter (LVPWDd) measured at end-diastole using 2D-targeted M-mode, according to 
the American Society of Echocardiography [16]. The LV posterior wall diameter in 
systole (LVPWDs) was also measured. LV wall mass (LVM) was calculated as 
1.05[(LVEDD + 2*LVPWDd)3 - LVEDD3]. Left atrial (LA) diameter was measured 
using M-mode in the parasternal short axis at the level of the aortic valve.  
Indices of LV systolic function were calculated using echocardiographically-
derived measurements. FS was calculated to measure LV contractility using the formula 
100*(LVEDD-LVESD)/LVEDD. The diameter of the LV outflow tract (LVOTd) was 
measured in the parasternal long axis view and was used to calculate the cross-sectional 
area (CSA) using the equation CSA = LVOTd2 * π/4. Outflow velocity of the LV outflow 
tract (LVOT) was measured by pulse wave Doppler interrogation in the long axis apical 
view, as recommended by the American Society of Echocardiography [17]. The velocity-
time integral (VTI) and ejection time (ET) were obtained from this pulsed wave Doppler 
measurement. ET was corrected for heart rate (ETc) using the equation ETc = ET/√RR. 
Stroke volume (SV, mL) was calculated as the product of the VTI and the CSA. Cardiac 
output (L/min) was calculated as the product of heart rate and SV divided by 1000.  
Meridonal wall stress (the tension within the wall of the LV) at peak systole (σPS) was 
calculated as 0.34*systolicBP*LVESD/LVPWDs*(1 + (LVPWDs/LVESD)) [18]. The 
mean velocity of circumferential fiber shortening (MVCFc) was derived from the 
equation (LVEDD-LVESD)/(ETc/1000*LVEDD). MVCFc is an indicator of myocardial 
performance that is sensitive to changes in contractile state, but it is highly dependent on 
loading conditions [19].  Therefore, we examined the relationship of MVCFc to σPS as a 
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preload independent, afterload-adjusted measure of cardiac contractility. To determine the 
relationship between σPS and MVCFc, the mean values for these variables for both the 
control and AN groups were plotted against published normal pediatric values [18].  
 Diastolic function was measured using pulse Doppler transmitral velocities, 
pulmonary venous velocities, and tissue Doppler measurements as recommended by the 
American Society of Echocardiography [20]. Mitral valve inflow was measured in the 
apical four chamber view with pulsed wave Doppler interrogation at the level of the 
mitral valve leaflets. The measurements made of mitral inflow included the peak early 
filling (E wave) and late diastolic filling (A wave) velocities, the deceleration time of the 
early filling velocity (DT), and the A wave duration. The inflow velocity E/A ratio was 
derived. Mitral valve propagation velocity was determined from the slope of the first 
aliasing velocity of the mitral valve inflow using colour M-mode at the center of the LV 
inflow blood column in the apical four chamber view. Pulsed wave Doppler interrogation 
of pulmonary venous flow was performed in the apical four chamber view with slight 
superior angulation using a sample volume placed 1-2 cm into the right upper pulmonary 
vein. The peak velocities of the systolic (S wave), early diastolic (D wave), and late 
diastolic (A wave) waves were measured as well as the A wave duration.  
TDI was acquired in the apical four chamber view with pulsed wave Doppler 
interrogation at the level of the cardiac base. The systolic (S’), early diastolic (E’), and 
late diastolic (A’) annular velocities were measured in the lateral LV wall, the 
interventricular septum (IVS), and the right ventricular (RV) free wall. These myocardial 
velocities measure the shortening or contraction (S’) and lengthening or relaxation (E’ 
and A’) of myocardial segments in the longitudinal plane [21, 22]. The ratio of mitral 
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valve inflow E wave velocity to tissue Doppler E’ (E/E’ ratio) was calculated, which has 
been shown to correlate with LV filling pressures [21].  
 
Body Size Indexing 
Body surface area was calculated using the DuBois formula BSA (m²) = 
0.20247(height)0.725(weight)0.425, with height measured in meters and weight in kilograms 
[23]. Standardization for body surface area (BSA) was performed by dividing the LVM, 
SV, and CO by the BSA to give the LVM index (LVMI), SV index (SVI), and cardiac 
index (CI), respectively. BMI percentiles were calculated for all subjects using data from 
the Centers for Disease Control growth data [24].  
 
Statistical Analysis 
We compared the mean parameters of the total group of AN patients to the control 
group using one way ANOVA. In order to determine the effect of the degree of patient 
malnutrition on echocardiographic parameters, we performed an additional subgroup 
analysis by dividing the AN group into those with a BMI less than or equal to the 10th 
percentile (lowest weight AN group) and those with a BMI greater than the 10th percentile 
(higher weight AN group). These subgroups were compared to the control group using a 
one way ANOVA with post-hoc analysis performed using Tukey’s test. Pearson’s 
product-moment correlations were performed to investigate the relationship between BMI 
percentile and the echocardiographic variables. Since the range of normal BMI varies 
across the age distribution of our subjects, BMI percentile for age was used instead of the 
absolute BMI value to determine the relationship of body composition to the different 
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echocardiographic parameters. Multivariable linear regression was performed to 
determine the relative contribution of age, systolic BP (sBP), heart rate, LVM, and BMI 
percentile on the E/A and E/E’ ratios. We also subdivided the AN group in those of the 
AN binge/purging subtype (AN-BP) and the AN restrictive subtype (AN-R) and 
compared these subtypes to control subjects using a one way ANOVA with post-hoc 
analysis performed using Tukey’s test. Due to the number of comparisons performed in 
our study, we considered p≤0.005 to indicate a statistically significant difference, p values 
of 0.005<p≤0.05 to be marginally statistically significant, and p values >0.05 to be non-
significant.  
 
Results 
Clinical Characteristics 
Ninety-seven patients with AN were identified from our echocardiographic 
database during the study period. Two patients were excluded from the analysis, one for 
absent height and BMI data and the other for evidence of LV non-compaction on the 
echocardiogram. There were a total of 95 young females in the AN group and 58 healthy 
young female controls. Table 1 outlines the baseline characteristics of the AN and control 
groups. The mean ages and heights of the AN and control groups were not significantly 
different. Twenty-two of the patients were AN-BP type and 73 were the AN-R type. The 
total AN group had a significantly lower weight, BMI, BSA, mean heart rate, sBP, and 
diastolic BP (dBP) as compared to control subjects. The distributions of BMI and BMI 
percentile for the AN and control groups are demonstrated in Figure 1.1A and 1.1B, 
respectively. Nine patients had mild myxomatous changes of the mitral valve or mitral 
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valve prolapse. Fifteen patients had mild to moderate pericardial effusions of no 
hemodynamic significance with the majority of these being trace or small effusions.  
The lowest weight AN subgroup was composed of 70 patients with 25 patients in 
the higher weight AN group. On subgroup analysis, the lowest weight AN group had 
significantly decreased weight, BSA, BMI, BMI percentile, sBP, and dBP as compared to 
the control group. The only significant differences between the higher weight AN group 
and controls were decreased BMI percentile, sBP, and dBP in the AN patients.  
Seventeen AN patients had more than one echocardiogram available for analysis. The low 
number of repeat assessments and the variability in the timing of the repeat assessments 
precluded further analysis of these repeat echocardiograms. 
 
Chamber Dimensions  
            Table 1.2 summarizes the comparison of LV dimensions and LA size in patients 
with AN compared to controls. LV dimensions including LVEDD, LVESD, IVSD, and 
LVPWDd were significantly smaller in patients with AN than in controls. BMI percentile 
correlated with LVEDD (r=0.356, p<0.001), LVESD (r=0.316, p<0.001), IVSD (r=0.299, 
p<0.001), and LVPWd (r=0.404, p<0.001). LVM was significantly reduced in the AN 
group as compared to the control group, and remained reduced when LVM was indexed 
for BSA. BMI percentile correlated with LVMI (r=0.340, p<0.001). LA size was also 
decreased in patients with AN and correlated with BMI percentile (r=0.419, p<0.001) and 
LVMI (r=0.368, p<0.001).  
 On subgroup analysis, the AN patients of lowest weight showed significant 
decreases in LV dimensions, LVM, LVMI, and LA size when compared to controls. In 
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contrast, the AN patients with a BMI >10th percentile showed no significant differences in 
these parameters when compared to controls.  
 
Left Ventricular Systolic Function 
The comparisons between the AN and control groups for LV function are outlined 
in Table 1.2.  Systolic ventricular function at rest, as measured by FS, was similar in 
patients with AN when compared to controls. Myocardial performance as measured by 
MVCFc and σPS showed no significant differences between the AN group and controls. 
As demonstrated in Figure 1.2, the relationship between MVCFc and σPS was normal for 
both the AN and control groups. SV was reduced in patients with AN compared to 
controls, however this difference was no longer statistically significant when SV was 
indexed for BSA. Both CO and CI were decreased in the AN group. The differences seen 
between the total AN group and controls were unchanged in the subgroup analysis 
comparing AN patients with a BMI ≤ 10th percentile to controls. Additionally, the lowest 
weight AN group had a significantly decreased wall stress as compared to controls. The 
subgroup analysis comparing the AN patients with a BMI > 10th percentile demonstrated 
no differences compared to controls in any of the parameters outlined in Table 1.2. The 
relationship between MVCFc and σPS remained normal for both AN subgroups, as 
demonstrated in Figure 1.2. BMI percentile correlated with SV (r = 0.366, p<0.001), CO 
(r = 0.436, p<0.001), and CI (r=0.250, p=0.002). There were no significant correlations 
between BMI percentile and FS, MVCFc, σPS, and SVI. 
  
43 
Left Ventricular Doppler Filling Pattern and Diastolic Function 
As summarized in Table 1.3, transmitral E wave velocity, A wave velocity and 
duration, DT, and propagation velocity were similar between groups. The E/A ratio was 
not different from controls for the total AN group, however, was significantly increased 
in the subgroup analysis when the AN patients of lowest weight were compared to 
controls. E/A ratio inversely correlated with BMI percentile (r =-0.229, p = 0.005) but not 
and LVMI. Transmitral A wave velocity correlated with BMI percentile (r = 0.208, 
p=0.012) but not LVMI. There were no significant correlations between transmitral E 
wave velocity, DT, or propagation velocity with LVMI or BMI percentile.  Multiple 
linear regression analysis was performed to assess the relative contribution of age, sBP, 
heart rate, BMI percentile, and LVM on the E/A ratio.  The model was statistically 
significant and explained a moderate amount of the variance in E/A, F(5,137)=11.035, 
p<0.001, adj R2=0. 287. Heart rate was the only independent predictor of the E/A ratio 
(β=-0.494, p<0.001). 
Pulmonary venous Doppler indices for the different groups are provided in Table 
1.3. Pulmonary venous S wave velocity, D wave velocity, and A wave duration showed 
no difference between patients with AN and controls. Pulmonary venous A wave velocity 
was significantly decreased in AN patients and the AN patients of lowest weight when 
compared to controls. Pulmonary venous A wave velocity correlated with BMI percentile 
(r=0.270, p=0.003) but not LVMI. There were no significant relationships between other 
pulmonary venous Doppler indices and BMI percentile or LVMI.  
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Pulsed Tissue Doppler Imaging 
Mean TDI indices for all groups are given in Table 1.4. The S’ wave of the base 
of the LV lateral wall, IVS, and RV free wall were similar between groups, indicating no 
difference in longitudinal systolic function as measured by TDI. The LV lateral wall and 
IVS peak E’ and A’ as well as the RV A’ velocities were significantly decreased in the 
AN group as compared to the control group. The LV lateral wall E/E’ ratio was 
significantly increased in the AN group as compared to controls. On subgroup analysis, 
LV lateral wall peak E’ and A’, IVS peak E’ and A’, and RV A’ velocities remained 
decreased in the lowest weight AN group when compared to controls. The AN patients 
with a BMI > 10th percentile had a significantly decreased RV A’ velocity compared to 
controls, with no other significant differences between these groups. The E/E’ ratio 
correlated inversely with BMI percentile (r=-0.230, p=0.006) with no significant 
correlation to LVMI. We performed multiple linear regression analysis using age, sBP, 
heart rate, BMI percentile, and LVM to predict the E/E’ ratio.  The model was statistically 
significant but explained only a small amount of the variance in E/E’, F (5,135)=2.285, 
p=0.050, adj R2=0. 044. None of the variables in the model were independent predictors 
of the E/E’ ratio.  
 
Comparison of AN Subtypes 
 The AN-R (n=73) patients showed no difference from the control group in age or 
height, but demonstrated significant decreases in weight (40.5 vs 51.2 kg, p<0.001), BSA 
(1.37 vs 1.52 m2, p<0.001), BMI (15.5 vs 19.7kg/m2, p<0.001), BMI percentile (7.3 vs 
45.5, p<0.001), sBP (95.4 vs 108.9mmHg, p<0.001), dBP (58.7 vs 65.3mmHg, p<0.001), 
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and heart rate (61.4 vs 69.4 beats/min, p=0.003). The AN-R patients showed reductions in 
LV dimensions compared to controls including LVEDD (4.28 vs 4.49 cm, p=0.011), 
LVESD (2.68 vs 2.82cm, p=0.037), IVSD (0.70 vs 0.76 cm, p=0.016), LVPWDd (0.67 vs 
.074 cm, p=0.002), LVM (103.4 vs 133.1 g, <0.001), LVMI (76.1 vs 85.9g/m2, p=0.012), 
and LA diameter (2.80 vs 3.06 cm, p=0.001). The hemodynamic parameters of SV (49.8 
vs 56.8mL, p=0.001), CO (2.96 vs 3.83 L/min, p<0.001), and CI (2.15 vs 2.55 L/min/m2, 
p<0.001) were decreased in the AN-R group compared to controls, with no differences in 
SVI, FS, MVCFc, or σPS.  Pulmonary venous A wave velocity was significantly 
decreased in the AN-R patients as compared to controls (0.15 vs 0.17, p=0.007) with no 
significant differences in other pulmonary venous or transmitral Doppler parameters. 
Analysis of the TDI results showed significant reductions in AN-R patients as compared 
to controls in LV lateral wall E’ (16.2 vs 18.1 m/s, p=0.006), IVS E’ (13.5 vs 15.1 m/s, 
p=0.001) and A’ (4.7 vs 5.9 m/s, p<0.001), and RV free wall A’ (6.6 vs 9.0 m/s, p<0.001) 
and an elevation of E/E’ in AN-R patients (5.8 vs 5.0, p = 0.004). 
AN-BP patients were significantly older than control patients (16.5 vs 15.1 yrs,  
p=0.017) with decreased BMI (17.8 vs 19.7kg/m2, p=0.005), BMI percentile (17.0 vs 
45.5, p<0.001), sBP (96.0 vs 108.9 mmHg, p<0.001), dBP (58.7 vs 65.3 mmHg, p<0.001) 
and heart rate (60.4 vs 69.4 beats/min, p = 0.025).  There were no significant differences 
in LA diameter, LV dimensions, or wall thickness other than a marginally significant 
reductions in LVPWDd (0.97 vs 0.74, p = 0.044), LVM (110.8 vs 133.1g, p=0.029), and 
LVMI (74.5 vs 85.9 g/m2, p=0.049). AN-BP patients demonstrated no differences from 
controls in FS, SV, SVI, CO, MVCFc, or σPS but had a marginally significant decrease in 
CI (2.20 vs 2.55L/min/m2, p=0.040).  There were no significant differences between AN-
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BP patients and controls in pulmonary venous or transmitral Doppler indices. There were 
no significant differences between the AN-BP and control groups in TDI parameters aside 
from a decreased RV A’ velocity in the AN-BP patients (6.0 vs 9.0m/s, p<0.001).  
Compared to AN-R patients, AN-BP patients were significantly older (16.5 vs 
15.2 yrs, p=0.034), and had a significantly increased BMI (17.8 vs 15.5 kg/m2, p=0.001) 
but no difference in BMI percentile (17 vs 7.3, p = 0.118).  
 
Discussion 
Our study demonstrates that in a large sample of adolescent females with AN, 
there are multiple differences in the structure and diastolic function of the heart as 
compared to female controls of normal weight. These differences include diminished 
chamber dimensions, disproportionately decreased LVM, decreased CI, and decreased 
diastolic TDI velocities. When the AN patient group is subdivided into patients with a 
BMI ≤10th percentile and > 10th percentile, it is the patient group with the greatest degree 
of malnutrition that shows significant differences in cardiac structure and function when 
compared to control subjects.  
 Patients with AN had significantly reduced resting heart rates when compared to 
the control group. This has been documented in multiple studies in both adolescents and 
young adult females [7, 8, 10, 13, 14, 25]. The reduced heart rate is likely related to an 
increase in vagal tone [14, 26, 27].  Galetta et al. (2002) demonstrated a decreased T3 
level in patients with AN, which is also seen in other patients with chronic malnutrition, 
and may be a contributing cause of bradycardia [28]. Other proposed contributors to the 
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presence of bradycardia have included electrolyte losses, adverse drug effects, reduced 
glycogen content of the myocardium, and myofibrillar atrophy [7]. 
 LV dimensions, LV wall thickness, LVM, and LA diameter were significantly 
decreased in patients with AN as compared to controls. These findings are in keeping 
with those of other studies investigating cardiac dimensions in AN [7-14]. In our study, 
mean LVM was reduced by approximately 20-25% in the total and low weight AN 
groups as compared to the control group. LVM remained significantly decreased despite 
indexing for BSA, indicating a disproportionately greater fall than would be expected 
based solely on the smaller body habitus of the females in the AN group. The correlation 
between BMI percentile and LVMI suggests that weight loss is accompanied by a 
reduction in the LVM. The etiology of the cardiac hypotrophy seen in AN has not been 
clearly elucidated. Possible causes include decreased afterload from relative hypotension 
leading to down-regulation of the LVM, reduced preload leading to ventricular 
remodeling, and a direct effect of malnutrition causing muscular atrophy as occurs in the 
skeletal musculature [8, 11, 26].  
 Despite the decreased LVM and LV dimensions, resting systolic function as 
assessed by FS and MVCFc was similar between the AN group and controls. These 
results are in keeping with the majority of published studies concerning systolic function 
at rest in AN, which have demonstrated no differences in EF, FS, or MVCFc [7-9, 11-14, 
26]. We found that patients with AN and controls had similar MVCFc, however, MVCFc 
is affected by LV afterload (or the BP) and patients with AN have been shown to have a 
significantly decreased BP compared to controls [8, 10, 11, 13, 14]. We therefore 
investigated the relationship between MVCFc and σPS, which is reported to be a preload 
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and afterload independent indicator of systolic function in the absence of ventricular 
outlet obstruction [18]. Our study demonstrates a normal MVCFc-σPS relationship in the 
total AN group and the AN subgroups, which suggests normal contractility at rest in 
patients with AN. Our study also demonstrates that σPS is similar between the AN and 
control groups, although the AN patients of lowest weight have a significantly decreased 
σPS as compared to controls. According to LaPlace’s law, LV wall stress is influenced by 
both LV afterload and wall thickness. As BP, LV dimensions, and wall thickness are 
decreased in our patients with AN, the net effect is that σPS remains relatively normal, 
although this compensation is not complete in the most malnourished AN patients. End-
systolic wall stress (which is closely related to σPS) in patients with AN has been 
investigated previously and has demonstrated conflicting results, with being unchanged 
when compared to controls by St. John Sutton et al. (1985) and lower than predicted for 
age by DiVasta et al. (2010) [11, 18, 26]. In our study, all TDI S’ wave velocities, which 
are a reflection of longitudinal systolic function, were unchanged between the AN groups 
and control subjects. Overall our results demonstrate no statistically significant decrease 
in systolic function at rest in adolescents with AN. There have, however, been some 
reports in the literature of subclinical impairment of LV systolic function in patients with 
AN. Eidem et al. (2001) found that adolescent females with AN had a significantly 
increased MPI, indicating a subclinical impairment in the active phase of LV function 
[12].  Galetta et al. (2005) demonstrated decreased LV S’ TDI velocities in young adult 
females with AN as compared to controls, which would indicate subclinical systolic 
impairment of the LV in patients with AN [13]. These findings by Galetta et al. (2005) 
are in disagreement with the findings in our study [13].  
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SV was decreased in our patients with AN compared to controls, however, this 
difference was no longer present once SV was indexed to BSA. Therefore, in relation to 
the BSA, there was no difference in the amount of blood ejected by the heart per beat. As 
a result of the relative bradycardia in our patients with AN, the amount of blood ejected 
per minute, or the CO, was decreased in the AN group and this difference was maintained 
when CO was indexed to the BSA. The decreased SV, CO, and CI are corroborated by 
other studies in patients with AN [8, 10]. As also shown by Romano et al. (2004), the 
combination of decreased BP and decreased SV demonstrated in our study is consistent 
with a low cardiac workload state which may contribute to the decrease in LVM in 
patients with AN [10].  
Abnormal LV filling patterns in AN patients have been previously documented 
with studies showing decreased transmitral peak A velocity and increased E/A ratio, 
indicating that the majority of LV filling occurs in early diastole [8, 13, 14]. Some authors 
have suggested that this diastolic pattern indicates impaired LV filling in patients with 
AN [8]. Other authors have felt that this filling pattern may be a physiologic adaptation to 
bradycardia as a decreased heart rate favours early diastolic filling, with a similar filling 
pattern also being seen in bradycardic athletes [14, 29]. The transmitral A wave velocity, 
which represents the contribution to LV filling from atrial contraction in late diastole, 
may be reduced due to more complete left atrial emptying occurring during the prolonged 
diastolic phase associated with bradycardia [14].  These previous studies which have 
assessed the transmitral Doppler patterns in AN have been performed in adult women and 
we are not aware of studies regarding these indices in pediatric patients. We found that 
E/A ratio was significantly increased in our adolescent patients with AN and a BMI ≤10th 
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percentile, however, we did not find a decrease in the peak A wave velocity. The 
difference in transmitral Doppler findings in our study compared to previous studies may 
be due to our patients being less bradycardic than the adult patients in these previous 
cohorts, which could account for less complete left atrial emptying in early diastole. To 
our knowledge, pulmonary venous Doppler velocities have not been previously studied in 
patients with AN. We found that the pulmonary venous A wave velocity was decreased in 
the total AN group and those with a BMI ≤10th percentile. Pulmonary venous A wave 
velocity reflects the velocity of blood flow reversal in the pulmonary veins as a result of 
atrial contraction. It is, therefore, conceivable that more complete LA emptying in 
prolonged diastole (similar to the rationale for decreased transmitral A wave velocity 
explained above) could lead to a decreased  pulmonary venous A wave velocity in 
patients with AN and bradycardia. The potential importance of heart rate leading to 
abnormalities in the transmitral, and possibly pulmonary venous, Doppler velocities is 
strengthened by the fact that our multiple linear regression analysis demonstrated that the 
only independent predictor of E/A ratio was heart rate, with E/A being inversely related 
to heart rate. The increased E/A ratio in AN patients with a BMI ≤10th percentile 
demonstrated in our study is suggestive of a restrictive pattern, but may not signify 
restrictive physiology. The transmitral and pulmonary venous Doppler indices may be 
difficult to interpret in AN as these indices can be altered by disturbances in preload, 
which is felt to be decreased in patients with AN [8]. This state of depressed preload is 
supported by our study as we found that patients with AN have decreased LA size, CO, 
CI, and SV as compared to control subjects. Due to the difficulty in assessing Doppler 
51 
filling patterns in the presence of decreased preload, any abnormalities in the transmitral 
or pulmonary venous Doppler velocities should be interpreted with caution.  
 In contrast to the results of transmitral and pulmonary venous velocity, our TDI 
results are more suggestive of disordered diastology in adolescent patients with AN. TDI 
velocities are measures of the longitudinal contraction and relaxation of the myocardium 
and are less preload dependent than transmitral indices [21, 22]. TDI measurements are 
helpful in differentiating people with diastolic dysfunction from normal individuals [30]. 
Patients in our study with AN had significantly decreased E’ velocities of the lateral LV 
wall and IVS and decreased  A’ velocities of the lateral LV wall, IVS, and RV free wall. 
These findings are in contrast to those of Galetta et al. (2005) who found no difference in 
the E’ and A’ velocities between their patients with AN and controls, although these 
authors acknowledged that their results were inconsistent with the evidence that diastolic 
dysfunction usually precedes systolic dysfunction [13]. We also found that the E/E’ ratio 
at the lateral wall, which correlates with LV filling pressure, was increased in patients 
with AN. This finding suggests that the LV filling pressures in patients with AN may be 
increased as compared to control subjects. Alterations in diastolic function and LV 
compliance would not be surprising in the setting of AN. In histologic studies of severely 
malnourished animals and humans, abnormalities of the myocardium have included gross 
edema, myofibrillar atrophy, interstitial edema, fibrosis, and cellular infiltration, which 
can result in reduced LV compliance [31-36]. Congestive heart failure (CHF) is an 
uncommon but reported complication seen in patients with AN that appears to be 
associated with the period of refeeding [35, 37, 38]. The mechanisms of heart failure in 
AN are unclear and are reported to include electrolyte deficiency, micronutrient 
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deficiency, and increased metabolic demand [37-39]. Although the clinical impact of this 
abnormal diastolic pattern is unknown, it is conceivable that in cases of severe AN 
diastolic dysfunction could contribute to the development of CHF in the setting of 
precipitously increased preload with inappropriate nutrient repletion and volume 
expansion [35].  
We performed a subgroup analysis in order to determine the effect of the severity 
of malnutrition in AN on echocardiographic findings. In discussion with our adolescent 
medicine colleagues, we chose to use the 10th percentile of BMI as the cutoff value in our 
subgroup analysis. Determination of a cutoff value of BMI or BMI percentile that confers 
risk of cardiac abnormalities in AN would require a larger study and was outside of the 
scope of our investigation. Our subgroup analysis demonstrated that the patients with AN 
and a BMI ≤ 10th percentile showed the same differences from controls as the total AN 
group, as well as an additional significant increase in the E/A ratio and decrease in σPS as 
compared to controls. In contrast, the patients with AN and a BMI > 10th percentile 
showed no differences from the controls aside from decreased mean BMI percentile, sBP, 
dBP, and TDI RV free wall A’ velocity. These results suggest that the abnormalities seen 
in cardiac dimensions and ventricular function in AN are related to the degree of 
malnutrition as the most severely malnourished patient group with AN demonstrated 
these differences. We are unaware of previous studies that have related BMI percentile to 
echocardiographic findings in pediatric cohorts of AN patients.  
We also investigated the echocardiographic changes in AN by subtype. We found 
that the differences in LV dimensions and diastolic function between the AN-R group and 
controls were similar to those found between the AN patients of BMI ≤ 10th percentile 
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and controls. In contrast, the patients with AN-BP had fewer differences from controls 
despite having lower BMI, BMI percentile, BP, and heart rate as compared to the control 
group. The AN-BP patients had a marginally significant reduction in LVM, LVMI, and 
CI with no other substantial differences in cardiac dimensions or diastolic function. AN-
BP patients had a higher mean BMI percentile than the AN-R patients, however, this 
difference was not statistically significant. Although part of the increased number of 
differences from controls among the AN-R patients could potentially be explained by a 
greater degree of malnutrition in this group, it is possible that differences in the 
physiology or the disease process between the AN-R and AN-BP patients may also 
partially explain the differences seen in the degree of cardiac changes.  
Limitations of our study include the retrospective case-control nature of the study 
and the potential biases associated with this design, including selection bias (as this study 
was performed at a tertiary care center and may have included more severely affected 
patients than the general AN population) and misclassification/information bias (via the 
misclassification of AN patients and their subtypes). We used a normal weight control 
group and did not compare the AN group to constitutionally thin females as other studies 
have done, however, the use of the thin weight control group did not substantially change 
the results of these studies compared to using the normal weight control group only [8, 
13, 14]. The measures of echocardiographic ventricular function in our study were only 
taken in the resting state and we were thus unable to determine the impact of 
hemodynamic stress on ventricular function. The retrospective nature of our study did not 
allow us to determine the MPI in our patients as simultaneous Doppler interrogation of 
ventricular inflow and outflow is not included in our lab’s detailed LV function protocol. 
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The number of controls in our study was fewer than the number of patients due to the 
difficulty of recruiting healthy adolescent female volunteers to undergo 
echocardiography. It is possible that an increased number of controls could have 
demonstrated additional significant differences between the patient and control groups. 
Although our results show no substantial differences in cardiac size and function between 
the AN patients with a BMI > 10th percentile and controls, we may have been 
underpowered to detect differences between these groups as the minority of patients in 
our cohort had a BMI percentile in this range. We may have also been underpowered to 
detect differences between the AN-BP group and controls as the majority of the patients 
in our study were of the AN-R subtype. Lastly, although our study demonstrates 
differences in echocardiographic parameters between patients with AN and controls, the 
clinical importance of such findings in unclear. DiVasta et al. (2010) found few truly 
pathologic cardiac findings in a cohort of adolescents hospitalized with AN and felt that 
less intensive cardiac monitoring may be reasonable in this patient population [26].  
 Further study is required to determine echocardiographic systolic and diastolic 
ventricular function in adolescent patients with AN during times of increased metabolic 
requirements. Despite our findings of normal systolic function and some changes in 
diastolic function at rest, it is possible that during times of hemodynamic stress that 
systolic or diastolic function could worsen in patients with AN and lead to deterioration. 
In addition, it is unclear if the abnormalities that we documented in our study are related 
to adaptation to the altered physiologic state in AN or if these are truly pathologic 
changes associated with AN. In order to help answer this question, future study on the 
reversibility of these findings with weight restoration is required. Although several 
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studies have investigated changes in systolic function and cardiac structure with weight 
restoration, little research has focused on the reversibility of diastolic abnormalities with 
weight restoration [6, 9, 11, 26, 40, 41]. It is possible that some of the histologic changes 
seen in starvation models, such as edema and cellular infiltration, are reversible while 
others, such as fibrosis, are not reversible with nutritional repletion. Our study is the first 
to document diastolic changes by TDI in patients with AN and are in contrast to the 
findings of Galetta et al. (2005) [13]. The difference in findings between our TDI analysis 
and that performed by Galetta et al. (2005) may be partially explained by the difference in 
mean age of our study subjects or by potential differences in disease severity and/or 
duration [13]. Due to these contrasting results, it is important for the findings of our TDI 
analysis to be repeated in a future study prior to drawing conclusions from these results.  
 In conclusion, the present study is one of the largest comprehensive 
echocardiographic studies of chamber dimensions and LV systolic and diastolic function 
which has been performed in adolescent females with AN. LV dimensions, wall 
thickness, and mass were decreased in the AN group, with a disproportionate decrease in 
LVM compared to the decrease in BSA. Systolic function was preserved at rest in our 
patient population. The TDI results are suggestive of a disturbance in diastolic function as 
compared to our control subjects. Our subgroup analysis demonstrated that the identified 
changes in cardiac size and function were present in the most malnourished patients with 
a BMI ≤ 10th percentile, with no substantial differences in the AN patients with less 
severe malnutrition and a BMI > 10th percentile. The AN patients of AN-R subtype 
demonstrated similar differences from controls as the AN patients of BMI ≤ 10th 
percentile, whereas those of AN-BP subtype demonstrated fewer changes in the 
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echocardiographic parameters studied. Further investigation is needed to fully assess the 
clinical relevance of the differences shown by our study in order to guide clinical follow 
up.   
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Table 1.1:  Baseline Characteristics of all Patients with AN and AN Subgroups Compared 
to Control Subjects 
  
Control Group 
(n=58) 
 
Total AN 
Group* 
(n=95) 
AN Subgroups§ 
BMI ≤10th 
percentile 
(n=70) 
BMI>10th 
percentile 
(n=25) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Age (years) 15.2 (2.6) 15.5 (1.7) 
p = 0.360 
15.4 (1.8) 
p = 0.702 
16.0 (1.3) 
p = 0.178 
Height (cm) 161.1 (9.1) 161.6 (8.4) 
p = 0.695 
161.4 (9.1) 
p = 0.820 
162.3 (6.2) 
p = 0.663 
Weight (kg) 51.7 (9.9) 42.2 (8.3) 
p < 0.001 
39.2 (6.7)  
p < 0.001 
50.2 (6.6) 
p = 0.874 
BSA (m2) 1.53 (0.18) 1.40 (0.16) 
p < 0.001 
1.36 (0.15)  
p < 0.001 
1.52 (0.12) 
p = 0.998 
BMI (kg/m2) 19.8 (2.7) 16.0 (2.4) 
p < 0.001 
15.0 (1.7)  
p < 0.001 
19.0 (1.5)  
p = 0.341 
BMI percentile 45.4 (25.9) 9.5 (15.5) 
p < 0.001 
2.2 (3.1)  
p < 0.001 
30.1 (17.7)  
p = 0.001 
Systolic BP 
(mmHg) 
108.8 (9.6) 95.5 (9.3) 
p < 0.001 
94.0 (9.4) 
p < 0.001 
99.6 (7.9) 
p < 0.001 
Diastolic BP 
(mmHg) 
65.0 (9.1) 58.2 (6.7) 
p < 0.001 
57.8 (6.4) 
p < 0.001 
59.5 (7.6) 
p = 0.007 
Heart rate (bpm) 69.4 (14.6) 61.2 (12.9) 
p < 0.001 
60.5 (13.3)  
p = 0.001 
63.1 (11.9) 
p = 0.131 
AN= Anorexia nervosa, SD = standard deviation, BP = blood pressure, BMI = body mass 
index 
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
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Table 1.2: Cardiac Dimensions and Left Ventricular Systolic Function in all Patients with 
AN and AN Subgroups Compared to Control Subjects  
  
Control 
Group 
(n=58) 
 
Total AN 
Group* 
(n=95) 
AN Subgroups§ 
BMI ≤10th 
percentile 
(n=70) 
BMI>10th 
percentile 
(n=25) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
LVEDD (cm) 4.49 (0.46) 4.31 (0.38) 
p = 0.009 
4.23 (0.36)  
p = 0.001 
4.54 (0.32) 
p = 0.862 
LVESD (cm) 2.82 (0.37) 2.69 (0.29) 
p = 0.018 
2.62 (0.27)  
p = 0.001 
2.90 (0.25) 
p = 0.545 
LVPWDd (cm) 0.74 (0.15) 0.67 (0.10) 
p < 0.001 
0.65 (0.10)  
p < 0.001 
0.71 (0.10) 
p = 0.546 
IVSD (cm) 0.76 (0.13) 0.70 (0.12) 
p = 0.005 
0.69 (0.11)  
p = 0.002 
0.75 (0.11) 
p = 0.911 
LA diameter (cm) 3.06 (0.34) 2.83 (0.39) 
p = 0.001 
2.77 (0.34)  
p < 0.001 
3.01 (0.47) 
p = 0.851 
LV mass (g) 133.1 (41.8) 105.1 (28.9) 
p < 0.001 
97.8 (26.3)  
p < 0.001 
125.7 (26.0) 
p = 0.623 
LV mass index 
(g/m2) 
85.9 (21.5) 75.8 (17.5) 
p = 0.002 
73.1 (16.3)  
p = 0.001 
83.3 (18.9) 
p = 0.830 
Fractional 
Shortening (%) 
37.3 (4.1) 37.4 (3.7) 
p = 0.759 
37.9 (3.8) 
p = 0.575 
36.1 (3.2) 
p = 0.417 
SV (mL) 56.8 (12.7) 50.1 (12.0) 
p = 0.001 
48.4 (11.0)  
p < 0.001 
54.6 (13.6) 
p = 0.714 
SVI  (mL/m2) 37.3 (6.2) 35.6 (7.2) 
p = 0.141 
35.5 (6.8) 
p = 0.308 
35.9 (8.4) 
p = 0.674 
CO (L/min) 3.83 (0.93) 3.04 (0.91) 
p < 0.001 
2.90 (0.83)  
p < 0.001 
3.43 (1.03) 
p = 0.156 
CI (L/min/m2) 2.55 (0.57) 2.16 (0.58) 
p < 0.001 
2.13 (0.56)  
p < 0.001 
2.26 (0.65) 
p = 0.088 
MVCFc  
(circumferences/s) 
1.15 (0.16) 1.20 (0.17) 
p = 0.082 
1.22 (0.18) 
p = 0.054 
1.14 (0.13) 
p = 0.983 
Stress at peak 
systole (dynes/cm2) 
60.1 (16.8) 56.0 (12.9) 
p = 0.096 
53.6 (12.4) 
p = 0.032 
62.8 (12.1) 
p = 0.712 
AN= Anorexia nervosa, SD = standard deviation, BMI = body mass index, LVEDD = left 
ventricular end-diastolic diameter, LVESD = left ventricular end-systolic diameter, 
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LVPWD = left ventricular posterior wall diameter, IVSD = interventricular septal wall 
diameter, LA = left atrium, LV = left ventricle, SV = stroke volume, SVI = stroke volume 
index, CO = cardiac output, CI = cardiac index, MVCFc = mean velocity of 
circumferential fiber shortening 
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
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Table 1.3: Transmitral and Pulmonary Venous Indices in all Patients with AN and AN 
Subgroups Compared to Control Subjects 
  
Control 
Group 
(n=51) 
 
Total AN 
Group* 
(n=95) 
 
AN Subgroups§ 
BMI ≤10th 
percentile 
(n=70) 
BMI>10th 
percentile 
(n=25) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
MV E wave 
velocity (m/s) 
0.87 (0.16) 0.90 (0.17) 
p = 0.232 
0.92 (0.17) 
p = 0.180 
0.85 (0.15) 
p = 0.878 
MV A wave 
velocity (m/s) 
0.37 (0.13) 0.35 (0.11) 
p = 0.239 
0.34 (0.10) 
p = 0.261 
0.37 (0.11) 
p = 0.993 
E/A ratio 2.54 (0.79) 2.85 (1.05) 
p = 0.062 
3.01 (1.11) 
p = 0.022 
2.43 (0.73) 
p = 0.880 
MV E wave 
deceleration time 
(ms) 
168.0 (46.3) 168.1 (40.4) 
p = 0.994 
164.5 (41.3) 
p = 0.894 
178.1 (36.5) 
p = 0.593 
MV A wave 
duration (ms) 
114.3 (18.3) 113.4 (16.5) 
p = 0.778 
111.5 (17.0) 
p = 0.652 
118.8 (13.7) 
p = 0.518 
MV propagation 
velocity (m/s) 
74.9 (23.1) 71.3 (29.3) 
p = 0.503 
70.2 (25.3) 
p = 0.680 
74.4 (38.5) 
p = 0.998 
PV S wave (m/s) 0.43 (0.12) 0.45 (0.13) 
p = 0.554 
0.45 (0.13) 
p = 0.800 
0.44 (0.13) 
p = 0.973 
PV D wave (m/s) 0.61 (0.13) 0.63 (0.14) 
p = 0.333 
0.63 (0.14) 
p = 0.569 
0.62 (0.11) 
p = 0.905 
PV A wave (m/s) 0.17 (0.04) 0.15 (0.04) 
p = 0.015 
0.14 (0.04) 
p = 0.005 
0.17 (0.05) 
p = 0.994 
PV A wave  
duration (msec) 
90.1 (18.2) 94.2 (21.3) 
p = 0.289 
92.3 (22.5) 
p = 0.851 
99.4 (17.0) 
p = 0.221 
AN= Anorexia nervosa, SD = standard deviation, BMI = body mass index, MV = mitral 
valve, PV = pulmonary venous 
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
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Table 1.4: Tissue Doppler Indices in all Patients with AN and AN Subgroups Compared 
to Control Subjects 
  
Control 
Group 
(n=50) 
 
 
Total AN 
Group* 
(n=95) 
 
AN Subgroups§ 
BMI ≤10th 
percentile 
(n=70) 
BMI>10th 
percentile 
(n=25) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
LV lateral base S’ 
(m/s) 
10.4 (2.0) 
 
10.4 (2.8) 
p = 0.965 
10.7 (2.7) 
p = 0.846 
9.6 (2.8) 
p = 0.411 
LV lateral base E’ 
(cm/s) 
18.1 (3.0) 16.5 (3.4) 
p = 0.006 
16.3 (3.6) 
p = 0.013 
16.9 (2.7) 
p = 0.304 
LV lateral base A’ 
(cm/s) 
5.5 (1.5) 4.8 (1.9) 
p = 0.034 
4.7 (1.9) 
p = 0.030 
5.3 (2.1) 
p = 0.912 
IVS base S’ (cm/s) 8.1 (1.1) 7.9 (1.5) 
p = 0.519 
8.0 (1.6) 
p = 0.932 
7.7 (1.3) 
p = 0.581 
IVS base E’ (cm/s) 15.1 (2.0) 13.7 (2.6) 
p = 0.001 
13.6 (2.6)  
p = 0.004 
13.7 (2.4) 
p = 0.055 
IVS base A’ (cm/s) 5.9 (1.1) 4.8 (1.5) 
p < 0.001 
4.6 (1.5)  
p < 0.001 
5.4 (1.4) 
p = 0.295 
RV base S’ (cm/s) 13.1 (1.6) 12.6 (2.3) 
p = 0.115 
12.7 (2.3) 
p = 0.580 
12.0 (2.3) 
p = 0.077 
RV base E’ (cm/s) 16.0 (2.9) 15.4 (3.7) 
p = 0.329 
15.7 (3.7) 
p = 0.923 
14.4 (3.4) 
p = 0.156 
RV base A’ (cm/s) 9.0 (2.6) 6.4 (2.5) 
p < 0.001 
6.1 (2.3)  
p < 0.001 
7.4 (2.8) 
p = 0.030 
MV E wave/LV 
lateral base E’ 
(cm/s) 
5.0 (1.1) 5.7 (1.5) 
p = 0.004 
5.9 (1.6) 
p = 0.001 
5.2 (1.2) 
p = 0.840 
AN= Anorexia nervosa, SD = standard deviation, BMI = body mass index, LV = left 
ventricle, IVS = interventricular septum, RV = right ventricle, MV = mitral valve 
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
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A.  
 
B.  
 
Figure 1.1. Frequency distributions of (A.) BMI and (B.) BMI percentile for the anorexia 
nervosa (AN) and control groups. BMI = body mass index. 
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Figure 1.2. Comparison of the relationship of meridional wall stress at peak systole (σPS) 
to the mean velocity of circumferential fiber shortening (MVCFc) in adolescent patients 
with anorexia nervosa (AN), control subjects, and the subgroups of AN patients with a 
BMI ≤ 10th percentile and those with a BMI > 10th percentile. The normal relationship 
between MVCFc and σPS is provided by the solid line and the equation MVCFc = -
0.0066σPS + 1.55, as determined by Sandor et al. (1992) [18].  The 95% confidence 
interval for this relationship is provided by the dashed lines. Permission to adapt this 
graph from the publication by Sandor et al. (1992) was obtained [18].  
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Chapter 3: Biophysical Properties of the Aorta in Adolescent Females 
with Anorexia Nervosa 
 
Abstract 
Background/Hypothesis: Anorexia nervosa (AN) is associated with cardiovascular 
complications and abnormalities of biomarkers associated with cardiovascular risk. 
Arterial stiffness, which is a risk factor for cardiovascular disease, has not been 
previously studied in patients with AN. This study aimed to determine the biophysical 
properties of the aorta in adolescent females with AN as compared to control subjects 
using Doppler echocardiography.  
Methods: This was a retrospective case-control study. Aortic diameter and pulse wave 
transit time were measured with echo-Doppler. Blood pressure was recorded at the time 
of the echocardiogram. Pulse wave velocity (PWV), aortic input impedance (Zi), 
characteristic impedance (Zc), arterial pressure-strain elastic modulus (Ep), and arterial 
wall stiffness index (β-index) were calculated. Patients were divided into those with BMI 
≤ or > 10th percentile to assess the effect of patient malnutrition on the biophysical 
properties of the aorta.   
Results: There were 94 adolescent females with AN and 60 adolescent female controls. 
There was no difference in age between AN patients and controls (15.5±1.7 vs 15.1±2.6 
years, p=0.220). BMI (16.0±2.4vs 19.7 ± 2.7, p<0.001) and BMI percentile (9.4±15.6.vs 
45.5 ± 26.2, p<0.001) were significantly lower for AN patients than for controls. PWV 
(443±106 vs 383±77cm/s, p<0.001), Zc (179±55 vs 149±37, p<0.001), and β-index 
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(3.07±1.09 vs 2.66±0.75, p=0.013) were significantly higher in AN patients than controls. 
There was no significant difference in Zi (198±53 vs 197±36, p=0.869) while Ep was 
decreased (232±84 vs 267±79, p=0.014) in AN patients compared to controls. PWV 
remained elevated compared to controls when AN patients were divided into those with 
BMI ≤ or > 10th percentile. Using multiple linear regression, the only significant 
predictor of PWV was the presence of AN.  
Conclusions: The increased PWV, which is the most sensitive indicator of vascular 
dysfunction, indicates increased aortic stiffness in adolescent females with AN compared 
to controls. Increased PWV was not related to the degree of patient malnutrition. Our 
study suggests that patients with AN may be at increased risk of future cardiovascular 
disease. Further studies are required to determine if these changes persist with treatment 
and to determine long term outcomes.  
 
Introduction 
 Anorexia nervosa (AN) is associated with many cardiovascular complications 
including electrophysiologic abnormalities, decreased left ventricular (LV) dimensions 
and wall mass, pericardial effusions, mitral valve prolapse, and reduced cardiac output [1-
4]. AN also has the highest mortality rate of any psychiatric disorder, with some of these 
deaths attributed to cardiac complications such as arrhythmias [1, 5, 6]. There have also 
been case reports of women with AN who experience myocardial infarction (MI) 
secondary to atherosclerosis at a much earlier age than anticipated [7-9]. Several studies 
have shown that women with AN have risk factors for future atherosclerotic 
cardiovascular disease including dyslipoproteinemia, elevated high sensitivity C-reactive 
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protein (hsCRP), and increased interleukin-6 (IL-6) [10-19]. The majority of studies 
regarding risk factors associated with future cardiovascular disease have been performed 
in adult populations [10-14, 16-19]. 
 Arterial stiffness is associated with cardiovascular disease including coronary 
artery disease and stroke [20, 21]. The most validated method of noninvasively measuring 
arterial stiffness is by measuring pulse wave velocity (PWV), which is defined as the 
speed with which a pulsatile blood wave travels along the length of an artery [20, 22]. 
PWV is a load-independent measure which is an independent predictor of stroke, 
coronary artery disease, and cardiovascular mortality in healthy and diseased adult 
populations [20, 21, 23-26]. PWV is considered the most sensitive and earliest indicator 
of cardiovascular risk [21, 27, 28]. PWV can be measured non-invasively using a simple 
Doppler echocardiography technique described by our laboratory [29]. Using this 
technique, the biophysical properties of the aorta including the PWV, characteristic 
impedance (Zc), input impedance (Zi), elastic pressure-strain modulus (Ep), and arterial 
wall stiffness index (β-index) can be assessed. Doppler echocardiography has been used 
to study the biophysical properties of the aorta in several pediatric and adult populations 
[29-37] and has been shown to be comparable with MRI-derived PWV measurements 
[38]. 
 To our knowledge, arterial stiffness as an indicator of cardiovascular risk has not 
been previously studied in patients with AN. The aim of our study was to assess the 
biophysical properties of the aorta in adolescent females with AN. Our hypothesis was 
that adolescent females with AN would demonstrate abnormalities of the biophysical 
properties of the aorta as compared to healthy adolescent female controls.  
73 
 
 
Methods 
Subjects 
We performed a retrospective case-control study of female adolescents with AN 
compared to female adolescent controls. The AN patients were referred by the Eating 
Disorders Program for routine cardiac assessment at the Children’s Heart Centre at 
British Columbia Children’s Hospital between October 2003 and August 2010. The 
diagnosis of AN was made clinically by a multidisciplinary team including psychiatry and 
adolescent medicine and was based on the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV) criteria. Patients were studied during the acute phase 
of presentation and treatment for AN.  
The control group was composed of healthy female adolescents from our 
established healthy control PWV database.  The controls were of normal weight and did 
not have a history of AN. The controls were volunteers recruited from friends and family 
of hospital employees. 
We recorded the echocardiographic data as well as height (cm), weight (kg), body 
mass index (BMI, kg/m2), body surface area (BSA, m2), heart rate (beats/min or bpm), 
systolic blood pressure (sBP, mmHg), diastolic blood pressure (dBP, mmHg), and pulse 
pressure (PP, mmHg) at the time of study. BSA was calculated using the DuBois formula 
BSA (m²) = 0.20247(height)0.725(weight)0.425, with height measured in meters and weight 
in kilograms [39]. BMI percentiles were calculated for all subjects using data from the 
Centers for Disease Control growth data [40]. We determined the length of illness as the 
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duration of time between the diagnosis of AN and the time of the echocardiographic 
study. Ethics approval for this study was obtained from the Children’s and Women’s 
Hospitals’ Research Ethics Board and the University of British Columbia’s Clinical 
Research Ethics Board.  
 
Doppler Echocardiography 
All subjects underwent a complete echocardiogram including our lab’s PWV 
protocol performed by an experienced echocardiographer. The biophysical properties of 
the aorta including the aortic stiffness and impedance indices were determined using 
Doppler echocardiography as previously described by our laboratory [29]. If patients had 
multiple cardiac assessments, only the data from the initial assessment were used. 
The diameter of the aortic annulus was measured at the level of the valve leaflets using 
two-dimensional (2D) echocardiography in the parasternal long-axis view. An M-mode 
recording of the ascending aorta was made from a high left or right parasternal view with 
the ascending aorta being kept as close to a right angle to the Doppler beam as possible. 
The maximum aortic diameter in systole (AOs) and the end-diastolic aortic diameter 
(AOd) were measured from this M-mode recording using the inner edge method. The 
aortic diameter measurements were averaged over three consecutive cardiac cycles. 
In a suprasternal long axis view, a pulsed wave Doppler recording of the 
ascending aorta was obtained by placing a sample volume in the center of the aorta at the 
level of the valve leaflets. The peak aortic velocity was measured from this Doppler 
tracing.  A pulsed wave Doppler recording of the descending aorta was then immediately 
obtained by placing the sample volume as distally as possible in the center of the 
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descending aorta. The ascending and descending aorta pulsed Doppler tracings were 
recorded at a speed of 100mm/s. These two tracings were recorded directly after one 
another to eliminate the possibility of a change in heart rate confounding the results. The 
time from the onset of the QRS to the onset of the ascending (T1) and descending (T2) 
aortic Doppler envelopes were measured over at least 3 cardiac cycles and were averaged. 
The transit time was calculated as the difference between these two times. Using the same 
suprasternal long axis view, the length of the aortic arch was measured along the central 
axis of the aorta using electronic calipers between the two points where the pulsed 
Doppler tracings were taken. Pulse wave Doppler interrogation in the long axis apical 
view was performed and the velocity-time integral (VTI) was obtained from this tracing. 
 
Calculations 
 We calculated hemodynamic parameters and biophysical properties of the aorta 
using the equations given in Table 2.1. 
 
Statistical Analysis 
Our primary outcome of interest was the aortic PWV. Secondary outcomes 
included the Zi, Zc, Ep, and β index.  
Univariate analysis was performed on all continuous variables. We compared the 
mean parameters of the total group of AN patients to the control group using a one way 
ANOVA. In order to determine the effect of the degree of patient malnutrition on the 
biophysical properties of the aorta, we performed an additional subgroup analysis by 
dividing the AN group into those with a BMI less than or equal to the 10th percentile and 
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those with a BMI greater than the 10th percentile. These subgroups were compared to the 
control group using a one way ANOVA with post-hoc analysis performed using Tukey’s 
test. We also subdivided the AN group in those of the AN binge/purging subtype (AN-
BP) and the AN restrictive subtype (AN-R). We compared these subtypes to control 
subjects and each other using a one way ANOVA with post-hoc analysis performed using 
Tukey’s test. We omitted the values of Ep and β-index from the analysis for one of the 
AN patients as these were outliers that distorted the statistical analysis. On review of the 
source data from this patient, the sampled plane of the aorta varied during the cardiac 
cycle, making the measurements of AOs and AOd inaccurate for this patient.  
We performed Pearson product moment correlations to investigate the 
associations between BMI percentile, BSA, age, heart rate, and AN duration on the 
biophysical properties of the aorta. Since the range of normal BMI varies across the age 
distribution of our subjects, BMI percentile for age was used instead of the absolute BMI 
value to determine the relationship of body composition to the biophysical properties of 
the aorta. Multivariable linear regression was performed to determine the relative 
contribution of presence of AN, BMI percentile, heart rate, sBP, and age on PWV. As 
total arterial compliance (TAC) is inversely related to heart rate and directly related to 
body size, we performed a multiple linear regression analysis to control for these 
variables and determine if presence of AN is an independent predictor of TAC [41]. Inter-
rater reliability for PWV was quantified using the intra-class correlation coefficient to 
assess absolute agreement using a two-way mixed model in a subset of 21 control 
patients. Due to the number of comparisons performed in our study, we considered 
p≤0.005 to indicate a statistically significant difference, p values of 0.005<p≤0.05 to be 
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marginally statistically significant, and p values >0.05 to be non-significant. All statistical 
analyses were performed using SPSS Statistics, version 17.0 (SPSS Statistics for 
Windows, Version 17.0, SPSS Inc., Chicago).  
 
Results 
Ninety-seven patients with AN were identified from our echocardiographic 
database during the study period. Three patients were excluded from the analysis: one for 
absent height and BMI data, another for evidence of LV non-compaction on the 
echocardiogram, and one for not having the PWV protocol performed. There were 94 
adolescent females in the AN group and 60 healthy adolescent female controls. Table 2.2 
summarizes the baseline characteristics of the AN and control groups. There were no 
significant differences in the mean age or height of the AN and control groups. The total 
AN group had a significantly lower mean weight, BMI, BMI percentile, BSA, mean heart 
rate, sBP, dBP, and PP as compared to control subjects. The lowest weight AN subgroup 
consisted of 70 patients with 24 patients in the higher weight AN group. On subgroup 
analysis, the AN patients with a BMI ≤10th percentile had significantly decreased mean 
weight, BSA, BMI, BMI percentile, heart rate, sBP, dBP, and PP as compared to the 
control group. The only significant differences between the AN patients with a BMI >10th 
percentile and controls were decreased BMI percentile, sBP, and dBP. The mean time 
from diagnosis of AN to the time of study was 97 days (range 8-1009 days).  
 Hemodynamic parameters for all groups are provided in Table 2.3. When 
compared to controls, the total AN group had significantly decreased peak aortic velocity, 
peak aortic flow (AOflow), stroke volume (SV), and cardiac output (CO). AN patients 
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with a BMI ≤10th percentile had significantly decreased peak aortic velocity, SV, and CO 
compared to controls, while there were no differences between the controls and AN 
patients with a BMI > 10th in any of the parameters outlined in Table 2.3. There were no 
differences in aortic annulus diameter, aortic cross sectional area (AOCSA), or total 
arterial compliance (TAC) between controls and the total AN group or the AN patients 
with BMI ≤ 10th percentile and > 10th percentile. Multiple linear regression analysis was 
performed using TAC as the dependent variable and presence of AN, height, weight, and 
heart rate as independent variables. The model was statistically significant and explained 
a small amount of the variance in TAC, F(4,139)=10.420, p<0.001, adj R2=0.209. 
Presence of AN was not an independent predictor of TAC (p=0.116) although heart rate 
(β= -0.326, p<0.001) and weight (β= 0.258, p=0.034) were independent predictors.  
 The biophysical properties of the aorta for the total AN group as compared to 
controls are summarized in Table 2.4. The PWV was significantly increased in AN 
patients as compared to controls. In addition, Zc and β-index were significantly increased 
and Ep was significantly decreased in AN patients as compared to controls. Zi was 
similar between the AN and control groups. On subgroup analysis, PWV and Zc 
remained significantly increased for both the BMI ≤ 10th percentile and BMI >10th 
percentile subgroups as compared to controls. Ep remained significantly decreased and β-
index trended towards being significantly increased in the AN patients with a BMI ≤ 10th 
percentile, with no significant changes in AN patients with a BMI >10th percentile.  
 There was no correlation between PWV or β–index and BMI percentile, BSA, 
heart rate, or age. Zi correlated with heart rate (r=0.176, p=0.031) and inversely correlated 
with BSA (r=-0.311, p<0.001) and age (r=-0.354, p<0.001). Zc inversely correlated with 
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BMI percentile (r=-0.212, p=0.008), BSA (r= -0.371, p<0.001), and age (r= -0.213, 
p=0.008). Ep correlated with heart rate (r=0.287, p=0.001), BMI percentile (r=0.226, 
p=0.006), BSA (r=0.333, p<0.001), and age (r= 0.233, p=0.005). There was no 
correlation between the time since diagnosis of AN at the time of study and the 
biophysical properties of the aorta. Multiple linear regression analysis using PWV as the 
dependent variable and presence of AN, heart rate, BMI percentile, sBP, and age as 
independent variables produced a statistically significant model which explained a small 
amount of the variability in PWV, F(5,144)=2.506, p=0.005, adj R2=0.078. The only 
significant predictor of PWV was the presence of AN (β=0.344, p=0.003) with an 
unstandardized β=71.479.  
Twenty-two of the AN patients were of the AN-BP subtype and 72 were the AN-
R subtype. As shown in Table 2.5, patients with AN-R had similar age and height as 
controls with decreased weight, BSA, BMI, BMI percentile, sBP, dBP, heart rate, and PP 
compared to controls. In comparison to control patients, patients with AN-BP were older 
and had similar height, weight, BSA, and PP. AN-BP patients had decreased BMI, BMI 
percentile, sBP, dBP, and heart rate compared to controls. When compared to AN-BP 
patients, AN-R patients were younger (p=0.028) and had decreased weight (p=0.002), 
BSA (p=0.009), and BMI (p<0.001) with no significant differences in height (p=0.420), 
BMI percentile (p=0.112), sBP (p=0.966), dBP (p=0.582), heart rate (p=0.957), or PP 
(p=0.404). The hemodynamic parameters and biophysical properties of the aorta in the 
AN-R and AN-BP patients as compared to controls are shown in Table 2.5. Patients with 
AN-R had decreased peak aortic velocity, peak aortic flow, SV, and CO as compared to 
controls. AN-R patients had increased PWV and Zc as compared to controls, while the 
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differences in Ep and β index trended towards significance. The only significant 
difference in hemodynamic parameters and biophysical properties of the aorta between 
the AN-BP patients and controls was an increased PWV. There were no significant 
differences in hemodynamic parameters or biophysical properties of the aorta between 
AN-R and AN-BP patients. 
Our inter-rater reliability for determining PWV was good with an intra-class 
correlation coefficient of 0.856 (p<0.001).  
 
Discussion 
 To our knowledge, our study is the first to demonstrate increased arterial stiffness 
in patients with AN. In a large sample of adolescent females with AN, we found that 
PWV was significantly increased in comparison to controls. PWV is considered the gold 
standard index of aortic stiffness and an elevation in PWV has been demonstrated to be 
an independent, sensitive, and early indicator of cardiovascular risk in healthy adults as 
well as adults with hypertension, diabetes, and renal disease [21, 27, 28]. There are 
different methods available to assess PWV, including the carotid-femoral method, 
Doppler echocardiography, and MRI, with the carotid-femoral method being the most 
commonly used method in adult patients [22, 29, 38]. Our study used Doppler 
echocardiography, which has also been used to show elevations in aortic PWV in other 
pediatric populations including patients with a history of Marfan syndrome, inflammatory 
connective tissue disease, Kawasaki disease, systemic lupus erythematosus as well as 
obese children and those born small for gestational age [29, 31-34, 36, 42, 43]. 
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 Our study indicates that adolescent females with AN have a stiffer thoracic aorta 
than healthy controls. There are multiple mechanisms that have been associated with 
increased arterial stiffness including structural changes in collagen and elastin caused by 
inflammation, increased luminal pressure, and abnormalities of remodeling pathways, as 
well as changes in vascular smooth muscle tone which can be caused by abnormalities in 
angiotensin II, endothelin, oxidative stress, and nitric oxide [44]. The pathological 
processes that lead to a stiffer aorta in the setting of AN are unclear. One possible 
mechanism of increased aortic stiffness is endothelial dysfunction. It has been suggested 
that nitric oxide and its association with endothelial function may play a role in the 
stiffness of large arteries [45]. Patients with AN are nutritionally deficient in L-arginine, 
an aminoacid which helps maintain endogenous nitric oxide activity, and this deficiency 
may potentiate arterial stiffness and cardiovascular risk in this population [46]. Patients 
with AN also have abnormalities in the renin-angiotensin-aldosterone system, and it is 
possible that these abnormalities may play a role in arterial stiffness [47, 48]. Aortic 
stiffness impedes the ejection of blood from the LV, thus increasing the work of the heart 
which subsequently promotes cardiac hypertrophy. Despite the increase in arterial 
stiffness in the setting of AN, the heart may be able to continue normal function and 
circumvent a hypertrophic response as the relative hypotension associated with AN 
decreases the LV afterload and may counteract the effect of a stiffer aorta. Although we 
were able to document increased arterial stiffness in patients with AN, it is unknown if 
these changes are permanent or reversible. Studies have demonstrated that other 
cardiovascular changes including decreased LV mass, decreased LV dimensions, 
bradycardia, dyslipidemia, and cardiac output can be improved with weight restoration in 
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patients with AN, however, the effect of weight restoration on vascular properties has not 
been documented [3, 49, 50]. 
The finding of increased arterial stiffness in patients with AN may indicate that 
these patients have increased future cardiovascular risk including hypertension, coronary 
artery disease and stroke. Our findings, suggestive of potentially increased cardiovascular 
risk in patients with AN, are supported by literature indicating that patients with AN have 
abnormalities in biomarkers which are associated with cardiovascular risk. Multiple 
studies have shown that patients with AN have elevated cholesterol and 
dyslipoproteinemia when compared to controls [10, 11, 13, 14, 16-19, 51]. Abnormalities 
in inflammatory markers including hsCRP and IL-6 have also been documented in 
women with AN. Lawson et al. (2007) found that 20% of women with AN who were 
taking oral contraceptive pills had high-risk hsCRP levels [12]. In a study of 23 
adolescent girls with AN, Misra et al. (2006) reported an “uncoupling” of cardiovascular 
risk factors [15]. They found decreased hsCRP, low triglycerides, and elevated high 
density lipoprotein (HDL) levels which would suggest decreased cardiovascular risk, 
however, they also found increased IL-6, apolipoprotein B (ApoB), and increased ratios 
of ApoB/HDL and ApoB/low density lipoprotein (LDL) which indicate increased 
cardiovascular risk.  
There remains some controversy in the literature regarding cardiovascular risk in 
females with AN, as some studies have suggested an absence of risk factors associated 
with future cardiovascular disease. Arden et al. (1990) showed no difference in 
cholesterol values or LDL between patients with AN and controls at admission, although 
the authors acknowledged that the study may have been underpowered to detect a 
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difference between the groups [52]. Birmingham et al. (2003) found no difference in the 
intima-media thickness of the carotid artery, which correlates with coronary 
atherosclerosis, between AN patients with a history of chest pain and healthy controls 
[53, 54]. Although the actual risk of myocardial infarction (MI) and the contribution of 
the aforementioned risk factors to future cardiovascular events are unknown, there are 
case reports of MIs secondary to atherosclerosis in women aged 37-41 years [7-9]. 
Despite some negative studies regarding cardiovascular risk factors in AN, the literature 
supporting increased rates of dyslipoproteinemia and inflammatory biomarkers as well as 
the case reports of MI in patients with AN suggest that this patient population may be at 
increased cardiovascular risk. Although increased arterial stiffness can occur in the 
absence of abnormalities of biomarkers, our findings of elevated PWV in AN further 
strengthens the hypothesis that these patients may be at risk for future cardiovascular 
disease.  
 PWV did not correlate with BMI percentile and remained elevated in comparison 
to controls when patients were divided into those with BMI ≤ and > 10th percentile. Our 
study was thus not able to document a relationship between arterial stiffness and the 
degree of malnutrition. PWV also did not correlate with the time since diagnosis of AN in 
our patient population, although we only studied the PWV at the first available 
echocardiogram in the acute phase of treatment of AN. Investigation of patients with 
longer durations of illness would be needed to determine if there is a relationship between 
disease duration and arterial stiffness. We did not find a correlation between PWV and 
heart rate, however, we did not manipulate patient heart rate in our study to investigate its 
relationship with PWV. The relationship between PWV and heart rate has been shown 
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elegantly in studies of patients with pacemakers where an increase in the patient’s heart 
rate confers an increase in their PWV [55-57]. As such, relative bradycardia in our AN 
patients as compared to controls may be masking the degree of arterial stiffness in our 
patients with AN. The mechanism of PWV increase with tachycardia is poorly defined, 
although it has been suggested that there may be a reduction in the time for elastic recoil 
of the arterial wall due to a shortened cardiac cycle [55-57]. The results of our multiple 
linear regression analysis demonstrated that in a model using presence of AN, heart rate, 
BMI percentile, sBP, and age, the only independent predictor of PWV was presence of 
AN, and that the presence of AN increases the PWV by a mean of 71.5cm/s when the 
other variables in the model are held constant. The R2 value of our model was low 
indicating that there may be other factors which were not measured in our study that 
influence the degree of arterial stiffness in AN.  
 Analysis of the other measures of aortic stiffness demonstrates variable results in 
AN patients. In contrast to PWV, many of these indices are load-dependent indicators of 
aortic stiffness. Normal pressure and flow pulses of the arterial system consist of a set of 
sinusoidal waves or harmonics [58]. Impedance is the ratio of a pressure harmonic to the 
flow harmonic at the same frequency [58]. The aortic impedance spectrum represents the 
ratio of pressure and flow harmonics existing in the aortic root and is analogous to 
vascular resistance [33, 58]. The physical properties of the aorta, including the 
viscoelasticity, inertia, and aortic dimensions, determine the characteristic impedance 
(Zc) [33, 58]. Input impedance (Zi) represents the resistance to ejection of the LV in a 
pulsatile flow system and is influenced by reflected pressure and flow waves generated in 
the distal arterial tree [33, 58]. In addition to heart rate, height, and arterial branching 
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affecting the reflected waves, increased arterial stiffness also influences the timing of 
wave reflections to alter the aortic input impedance. Zc was significantly increased in the 
AN group due to the inclusion of PWV in the formula to calculate Zc. The elevation in Zc 
is consistent with increased aortic stiffness in AN patients as compared to controls. There 
was no difference in Zi between the AN groups and controls due to a significant decrease 
in both the peak aortic flow and PP in the AN group as compared to controls, which are 
both components of the equation to calculate Zi. The Ep and β index measures are 
attempts at applying Hooke’s law of stress and strain. Ep expresses the ratio of stress, or 
PP, to the strain, or the percent change in the arterial diameter during the cardiac cycle. 
The AN patients in our study showed a decrease in Ep as compared to controls, which 
would signify decreased arterial stiffness, but this decrease in Ep was likely caused by the 
significantly decreased PP in AN patients as compared to controls. β index is reported to 
be less load-dependent within the physiologic range of intravascular pressure than 
impedance values and Ep [59]. The elevation in β index in the AN group is consistent 
with increased aortic stiffness in AN patients as compared to controls.  
Total arterial compliance (TAC) characterizes the entire arterial tree and is the 
inverse of arterial stiffness [60]. TAC is used as a surrogate index of arterial stiffness such 
that increased stiffness results in TAC becoming decreased, and it is an independent 
predictor of cardiovascular events and mortality in patients with hypertension [60-62]. 
The AN patients in our study showed no difference in TAC as compared to control 
subjects. TAC is inversely related to heart rate and directly related to body size, but 
despite controlling for these factors, the presence of AN was not an independent predictor 
of TAC in our study [41]. TAC was estimated in our study by the ratio of PP to SV. This 
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method of estimation is based on an ejection phenomenon, and has been shown to 
correlate with Liu’s method of estimating TAC based on diastolic decay of the aortic 
pressure [63, 64]. However, the SV/PP method was derived in the setting of normal 
individuals based on their pattern of diastolic decay and may not be applicable in the AN 
population. 
Our study demonstrated mixed results when investigating the additional measures 
of the biophysical properties of the aorta. The increased Zc and β index in AN patients 
suggests increased arterial stiffness in this population, while the results of Zi, TAC, and 
Ep suggest either unchanged or decreased arterial stiffness. These additional measures of 
the biophysical properties of the aorta have their limitations and may be of questionable 
utility in the setting of our AN population due to the significant differences in the 
hemodynamic properties of the cardiovascular system in AN patients as compared to 
controls, particularly the relative hypotension and decreased PP, SV, CO, and peak aortic 
flow. Since PP, BP, SV, and peak aortic flow are used to calculate these other measures 
of arterial stiffness, the significant abnormalities in the hemodynamic parameters in AN 
patients may account for our mixed results.  The measures of Zi, Ep, β index, and TAC 
are also limited due to their load-dependence. PWV, in contrast, is not calculated using 
these hemodynamic parameters and is load-independent. Zc is heavily influenced by the 
value of PWV as this is a part of the equation used to calculate Zc. Therefore, the best 
indicator of arterial stiffness remains PWV which demonstrated increased arterial 
stiffness in our adolescent AN population. The increased PWV in AN was not related to 
the degree of patient malnutrition as assessed by BMI percentile; however, the patients 
with a BMI ≤10th percentile were more hemodynamically abnormal than those with a 
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BMI >10th percentile, and therefore had greater aberrations in the additional indices of 
aortic stiffness.  
 There have been indications of differences in the serum biomarkers associated 
with cardiovascular risk between AN subtypes. Case et al. (1999) compared fasting lipid 
levels in patients with bulimia nervosa (BN), AN-BP, and controls [51]. They found that 
the AN-BP patients had significantly higher cholesterol, ApoB, apolipoprotein A1, and 
LDL-cholesterol levels than BN patients and controls, and elevated triglycerides and 
intermediate-density lipoprotein-apoB levels when compared to controls [51]. Rigaud et 
al. (2009) found that total cholesterol and LDL-cholesterol levels were greater in AN 
patients with the binge-purge subtype than in those with the restrictive subtype [18]. Our 
study showed that PWV remained increased in comparison to controls for both the AN-R 
and AN-BP groups, and that there was no significant difference in aortic stiffness 
between the AN-R and AN-BP groups.  
Limitations of our study include the retrospective case-control nature of the study 
and the potential biases associated with this design including selection bias (as this study 
was performed at a tertiary care center and may have included more severely affected 
patients than the general AN population) and misclassification/information bias (via the 
misclassification of AN patients and their subtypes).  The method of measuring PWV 
using Doppler echocardiography has its limitations including difficulties in obtaining 
accurate aortic dimensions in the setting of poor echocardiographic windows and the 
potential for measurement error due to the small time differences between the onset of 
Doppler flow in the ascending and descending aorta. Although these limitations could 
potentially lead to making large differences in a single patient’s PWV due to small 
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measurement errors, the coefficient of variation for interobserver, intersessional, and 
inter-reviewer assessments has been reported to range between 2-16% [33], and our study 
demonstrated good inter-rater reliability in the calculation of PWV. We did not have the 
results of cholesterol or other serum biomarkers associated with cardiovascular risk and 
thus were not able to relate these risk factors to PWV. TAC and the biophysical properties 
of the aorta other than PWV have their limitations as they are calculated using 
hemodynamic variables, as discussed previously. The validity of using these calculated 
values is unclear in the face of the significant differences in multiple hemodynamic 
parameters seen in AN patients as compared to controls. We also did not assess the wave 
reflection of the arterial tree in the AN patients. The number of control patients in our 
study was fewer than the number of patients due to the difficulty of recruiting healthy 
adolescent female volunteers to undergo echocardiography. It is possible that an increased 
number of control patients could have demonstrated further differences between the 
patient and control groups. As well, due to the minority of patients having a BMI >10th 
percentile or the AN-BP subtype, we may have been underpowered to detect differences 
between these groups and controls.  
 Future studies are required in order to determine the reversibility of the arterial 
changes in patients with AN following weight restoration. The impact of increased 
arterial stiffness or any of the serum biomarkers associated with cardiovascular risk on 
the incidence of MI in AN is also unknown. The effect of hemodynamic stress or exercise 
on the biophysical properties of the aorta in patients with AN would also be an area of 
future investigation. As there is no other published literature on arterial stiffness in AN, it 
is important for the results of the present investigation to be repeated in future studies.  
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 In conclusion, this is the first study to investigate arterial stiffness as indicated by 
PWV in adolescent patients with AN using Doppler echocardiography. PWV was 
significantly elevated in adolescent patients with AN. Increased PWV in AN was not 
related to the degree of patient malnutrition as assessed by BMI percentile. Our study 
suggests that patients with AN may be at increased risk for future cardiovascular disease.  
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Table 2.1 Formulae for Calculating the Biophysical Properties of the Aorta 
Parameter Formula 
AOCSA 
(cm2) 
(π/4) (aortic annulus diameter)2 
AOflow 
(cm3/s) 
(peak aortic velocity) · AOCSA 
SV 
(mL) 
VTI · AOCSA 
CO 
(L/min) 
(Heart rate) · SV/1000 
PP 
(mmHg) 
sBP-dBP 
TAC 
(mL/mmHg) 
SV/PP 
TT 
(s) 
T2 – T1 
(T2 = time from onset of QRS to onset of descending aortic Doppler 
envelope; T1 = time from onset of QRS to onset of ascending aortic 
Doppler envelope) 
PWV 
(cm/s) 
aortic length/TT 
Ep  
(mmHg) 
PP/[(AOs – AOd)/AOd] 
β index ln(sBP/dBPd)/[(AOs-AOd)/AOd] 
Zi 
(dyne·s/cm5) 
PP/AOflow 
Zc 
(dyne·s/cm5) 
PWV·ρ/AOCSA 
(ρ is the density of blood = 1.06 g/cm3) 
AOCSA = aortic cross-sectional area, AOflow = peak aortic flow, SV = stroke volume, 
VTI = velocity time integral, CO = cardiac output, TT = transit time, PWV = pulse wave 
velocity, Ep = Elastic pressure-strain modulus, sBP = systolic blood pressure, dBP = 
diastolic blood pressure, AOs = maximum aortic diameter, AOs = end-diastolic aortic 
diameter, β-index = Arterial wall stiffness index, PP = pulse pressure, Zi = Input 
impedance, Zc = Characteristic impedance, 1 mmHg = 1,333 dyne/cm2, ρ = blood density 
= 1.06 g/cm3  
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Table 2.2:  Baseline Characteristics of all Patients with AN and AN Subgroups Compared 
to Control Subjects 
  
Control Group 
(n=60) 
 
Total AN 
Group* 
(n=94) 
AN Subgroups§ 
BMI ≤10th 
percentile 
(n=70) 
BMI>10th 
percentile 
(n=24) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Age (years) 15.1 (2.6) 15.5 (1.7) 
p = 0.220 
15.4 (1.8) 
p = 0.702 
15.9 (1.2) 
p = 0.249 
Height (cm) 160.5 (9.8) 161.6 (8.5) 
p = 0.446 
161.4 (9.1) 
p = 0.821 
162.1 (6.3) 
p = 0.723 
Weight (kg) 51.2 (10.3) 42.0 (8.2) 
p < 0.001 
39.2 (6.7)  
p < 0.001 
50.1 (6.8) 
p = 0.856 
BSA (m2) 1.52 (0.19) 1.40 (0.16) 
p = 0.002 
1.36 (0.15)  
p < 0.001 
1.52 (0.12) 
p = 1.000 
BMI (kg/m2) 19.7 (2.7) 16.0 (2.4) 
p < 0.001 
15.0 (1.7)  
p < 0.001 
19.0 (1.6)  
p = 0.359 
BMI percentile 45.5 (26.2) 9.4 (15.6) 
p < 0.001 
2.2 (3.1)  
p < 0.001 
30.6 (17.9)  
p = 0.002 
Systolic BP 
(mmHg) 
108.9 (9.5) 95.5 (9.3) 
p < 0.001 
94.0 (9.4) 
p < 0.001 
99.6 (7.9) 
p < 0.001 
Diastolic BP 
(mmHg) 
65.3 (9.1) 58.2 (6.7) 
p < 0.001 
57.8 (6.4) 
p < 0.001 
59.5 (7.6) 
p = 0.007 
Heart rate 
(bpm) 
69.4 (14.6) 61.1 (13.0) 
p < 0.001 
60.5 (13.3)  
p = 0.001 
62.9 (12.1) 
p = 0.126 
Pulse pressure 
(mmHg) 
43.6 (7.8) 37.3 (7.5) 
p < 0.001 
36.3 (7.4) 
p < 0.001 
40.1 (7.1) 
p = 0.133 
AN= Anorexia nervosa, SD = standard deviation, BP = blood pressure, BMI = body mass 
index 
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
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Table 2.3: Hemodynamic Parameters in all Patients with AN and AN Subgroups 
Compared to Control Subjects  
  
Control Group 
(n=60) 
 
Total AN 
Group* 
(n=94) 
AN Subgroups§ 
BMI ≤10th 
percentile 
(n=70) 
BMI>10th 
percentile 
(n=24) 
  Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Aortic 
Annulus 
Diameter (cm) 
1.86 (0.17) 1.85 (0.17) 
p = 0.740 
1.85 (0.17) 
p = 0.855 
1.87 (0.16) 
p = 0.968 
AOCSA (cm2) 2.74 (0.49) 2.72 (0.49) 
p = 0.743 
2.70 (0.50) 
p = 0.863 
2.77 (0.45) 
p = 0.974 
Peak aortic 
velocity (m/s) 
1.08 (0.16) 0.99 (0.18) 
p = 0.002 
0.98 (0.19) 
p = 0.004 
1.01 (0.16) 
p = 0.247 
AOflow 
(cm3/s) 
2.91 (0.58) 2.68 (0.68)  
p = 0.039 
2.64 (0.69) 
p = 0.057 
2.80 (0.63) 
p = 0.765 
AOd (cm) 2.05 (0.25) 2.04 (0.27) 
p = 0.776 
2.03 (0.30) 
p = 0.846 
2.08 (0.19) 
p = 0.914 
AOs (cm) 2.40 (0.24) 2.39 (0.27) 
p = 0.760 
2.37 (0.30) 
p = 0.799 
2.43 (0.19) 
p = 0.855 
AOs-
AOd/AOd 
0.174 (0.047) 0.174 (0.056) 
p = 0.934 
0.175 (0.057) 
p = 0.994 
0.174 (0.052) 
p = 1.000 
SV (mL) 56.8 (12.7) 50.1 (12.0) 
p = 0.001 
48.4 (11.0)  
p < 0.001 
55.0 (13.7) 
p = 0.807 
CO (L/min) 3.83 (0.93) 3.04 (0.92) 
p < 0.001 
2.90 (0.83)  
p < 0.001 
3.45 (1.04) 
p = 0.197 
TAC 
(mL/mmHg) 
1.29 (0.34) 1.39 (0.41) 
p = 0.153 
1.38 (0.40) 
p = 0.452 
1.41 (0.44) 
p = 0.394 
AN= Anorexia nervosa, SD = standard deviation, BMI = body mass index 
AOCSA = aortic cross-sectional area, AOflow = peak aortic flow, AOd = diastolic 
diameter of the ascending aorta, AOs = systolic diameter of the ascending aorta, SV = 
stroke volume, CO = cardiac output, TAC = total arterial compliance 
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
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Table 2.4:  Biophysical Properties of the Aorta in all Patients with AN and AN Subgroups 
Compared to Control Subjects 
  
Control Group 
(n=60) 
 
Total AN 
Group* 
(n=94) 
AN Subgroups§ 
BMI ≤10th 
percentile 
(n=70) 
BMI>10th 
percentile 
(n=24) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
PWV 
(cm/s) 
383 (77) 443 (106) 
p < 0.001 
439 (107) 
p = 0.003 
454 (106) 
p = 0.007 
Zi 
(dyne·s/cm5) 
197 (36) 198 (53) 
p = 0.869 
198 (53) 
p = 0.995 
200 (56) 
p = 0.971 
Zc 
(dyne·s/cm5) 
149 (37) 179 (55) 
p < 0.001 
178 (56) 
p = 0.002 
179 (54) 
p = 0.027 
Ep  
(mmHg) 
267 (79) 232 (84) 
p = 0.014 
230 (89) 
p = 0.040 
238 (73) 
p = 0.347 
β index 2.66 (0.75) 3.07 (1.09) 
p = 0.013 
3.06 (1.12) 
p = 0.058 
3.08 (1.01) 
p = 0.190 
AN= Anorexia nervosa, SD = standard deviation, BMI = body mass index, PWV = pulse 
wave velocity, Zi = Input impedance, Zc = Characteristic impedance , Ep = Elastic 
pressure-strain modulus, β-index = Arterial wall stiffness index 
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
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Table 2.5 Hemodynamic Parameters and Biophysical Properties of the Aorta in Patients 
with AN Divided by Subtype Compared to Controls 
 Control Group 
(n=60) 
AN Restrictive 
Subtype* 
(n=72) 
AN Binge-Purge 
Subtype* 
(n=22) 
 Mean (SD) Mean (SD) Mean (SD) 
Age (years) 15.1 (2.6) 15.2 (1.7) 
p = 0.938 
16.5 (1.1) 
p = 0.017 
Height (cm) 160.5 (9.8) 160.9 (9.1) 
p = 0.948 
163.7 (5.4) 
p = 0.318 
Weight (kg) 51.2 (10.3) 40.3 (8.1)  
p < 0.001 
47.6 (6.1) 
p = 0.236 
BSA (m2) 1.52 (0.19) 1.37 (0.16) 
p < 0.001 
1.49 (0.10) 
p = 0.850 
BMI (kg/m2) 19.7 (2.7) 15.4 (2.3) 
p < 0.001 
17.8 (2.1) 
p = 0.005 
BMI percentile 45.5 (26.2) 7.1 (12.5) 
p < 0.001 
17.0 (21.5) 
p < 0.001 
Systolic BP 
(mmHg) 
108.9 (9.5) 95.4 (8.6) 
p < 0.001 
96.0 (11.7) 
p < 0.001 
Diastolic BP 
(mmHg) 
65.3 (9.1) 58.7 (6.7) 
p < 0.001 
56.8 (6.9) 
p < 0.001 
Heart rate (bpm) 69.4 (14.6) 61.4 (13.7) 
p = 0.003 
60.4 (10.6) 
p = 0.026 
Pulse pressure 
(mmHg) 
43.6 (7.8) 36.8 (7.2) 
p < 0.001 
39.2 (8.4) 
p = 0.058 
Aortic Annulus 
Diameter (cm) 
1.86 (0.17) 1.84 (0.18) 
p = 0.822 
1.88 (0.12) 
p = 0.902 
AOCSA  
(cm2) 
2.74 (0.49) 2.70 (0.52) 
p = 0.842 
2.79 (0.36) 
p = 0.932 
Peak aortic velocity  
(m/s) 
1.08 (0.16) 0.9 (0.18) 
p = 0.002 
1.04 (0.19) 
p = 0.588 
AOflow  
(cm3/s) 
2.91 (0.58) 2.63 (0.69) 
p = 0.036 
2.88 (0.59) 
p = 0.970 
AOd (cm) 2.05 (0.25) 2.04 (0.29) 
p = 0.944 
2.05 (0.20) 
p = 0.998 
AOs (cm) 2.40 (0.24) 2.38 (0.29) 
p = 0.883 
2.41 (0.21)  
p = 0.972 
95 
AOs-AOd/AOd 0.174 (0.047) 0.172 (0.058) 
p = 0.987 
0.181 (0.049) 
p = 0.824 
SV  
(mL) 
56.8 (12.7) 48.8 (11.6) 
p = 0.001 
54.3 (12.7) 
p = 0.683 
CO  
(L/min) 
3.83 (0.93) 2.96 (0.89) 
p < 0.001 
3.29 (0.97)  
p = 0.053 
TAC  
(mL/mmHg) 
1.29 (0.34) 1.37 (0.40) 
p = 0.503 
1.44 (0.45) 
p = 0.279 
PWV 
(cm/s) 
383 (77) 439 (105) 
p = 0.003 
456 (113) 
p = 0.007 
Zi 
(dyne·s/cm5) 
197 (36) 201 (56) 
p = 0.843 
187 (40) 
p = 0.685 
Zc 
(dyne·s/cm5) 
149 (37) 179 (58) 
p = 0.001 
176 (46) 
p = 0.066 
Ep  
(mmHg) 
267 (79) 235 (91) 
p = 0.080 
224 (61) 
p = 0.117 
β index 2.66 (0.75) 3.07 (1.15)  
p = 0.051 
3.07 (0.87) 
p = 0.244 
AN= Anorexia nervosa, SD = standard deviation, BP = blood pressure, BMI = body mass 
index, AOCSA = aortic cross-sectional area, AOflow = peak aortic flow, AOd = diastolic 
diameter of the ascending aorta, AOs = systolic diameter of the ascending aorta, SV = 
stroke volume, CO = cardiac output, TAC = total arterial compliance, PWV = pulse wave 
velocity, Zi = Input impedance, Zc = Characteristic impedance , Ep = Elastic pressure-
strain modulus, β-index = Arterial wall stiffness index 
* p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subtypes to controls 
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Chapter 4: Exercise Capacity and Ventricular Function during 
Semisupine Stress Cycle Ergometry in Adolescent Females with 
Anorexia Nervosa 
 
Abstract 
Background: Patients with anorexia nervosa (AN) have altered physiological responses to 
exercise. We investigated exercise capacity and echocardiographic ventricular function 
with exercise in adolescent patients with AN.  
Methods: This was a retrospective case-control study. Sixty-six adolescent females with 
AN and 21 adolescent female controls exercised on a semi-recumbent ergometer to 
volitional fatigue in 3 minute states with 20 watt increments. Heart rate (HR), blood 
pressure (BP), and echo-doppler indices were measured at rest and at each stage. 
Fractional shortening (FS), mean velocity of circumferential fiber shortening (MVCFc), 
cardiac output (CO), cardiac index (CI), total arterial compliance (TAC), and systemic 
vascular resistance (SVR) were calculated at rest and each stage of exercise. Peak oxygen 
consumption (VO2), minute ventilation (VE), and respiratory exchange ratio (RER) were 
measured using open-circuit spirometry.  
Results: Patients with AN had a significantly lower BMI (16.7 vs 19.7kg/m2, p<0.001), 
total work (1125 vs 1914J/kg, p<0.001), and test duration (13.8 vs 20.8min, p<0.001) 
when compared to controls. Multivariable linear regression demonstrated that BMI 
percentile, age, peak VO2, and peak CO were significant independent predictors of 
exercise duration. Total work, peak VE, and peak VO2 were significantly decreased in 
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AN patients. HR, systolic BP, CO, CI, FS, and MVCFc demonstrated similar patterns of 
increase with progressive exercise between groups, but were decreased at peak exercise in 
AN patients. At peak exercise, SVR was similar between groups and TAC was increased 
in patients with AN, with similar patterns of response to progressive exercise.  
Conclusions: Adolescent patients with AN have reduced exercise capacity compared to 
controls but have normal patterns of cardiovascular response to progressive exercise. 
Exercise endurance is independently predicted by BMI percentile. 
 
 
Introduction 
 Cardiac involvement occurs in approximately 80% of patients with anorexia 
nervosa (AN) [1-3]. These cardiovascular changes include reductions in heart rate (HR), 
blood pressure (BP), myocardial mass, left ventricular (LV) dimensions, and resting 
cardiac output (CO) [1-7]. Multiple studies have demonstrated that standard measures of 
systolic ventricular function at rest are unchanged in patients with AN [3-5, 7, 8]. There 
are, however, some studies that suggest possible subclinical cardiac dysfunction in 
patients with AN as abnormalities in the myocardial performance index and systolic 
tissue Doppler velocities have been described in this patient population [8, 9].  
Exercise imposes physiologic and hemodynamic stresses on the cardiovascular 
system. Normal exercise endurance necessitates adequate myocardial performance to 
maintain stroke volume (SV) and CO. In the setting of abnormalities of the cardiac 
system and suggestions of subclinical systolic ventricular dysfunction in AN, it is 
important to determine myocardial performance with exercise in this patient population. 
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Patients with AN have been reported to have reduced exercise endurance, decreased 
maximal oxygen uptake (VO2), and blunted HR and BP responses with exercise [7, 10-
12]. Information regarding myocardial performance and contractility with exercise and 
the pattern of cardiovascular response to staged physical activity in patients with AN is 
limited. Rowland et al. (2003) studied 8 adolescent females with AN compared to healthy 
controls using an upright cycle ergometer and found decreased VO2, increased SV index 
(SVI), and no change in the cardiac index (CI) in patients with AN compared to controls 
[13]. To our knowledge, there are no studies investigating myocardial function during 
exercise using echocardiography in patients with AN. In addition, the few studies that 
have been performed investigating the cardiovascular responses to exercise in AN have 
been limited by small sample sizes.  
Myocardial function can be studied using echocardiographic measurements taken 
while a patient is exercising using semi-supine cycle ergometry (SSCE) stress 
echocardiography. This methodology allows for measurement of SV, CO, cardiac 
contractility, and load-independent myocardial function in addition to the standard indices 
of exercise tolerance, BP, and HR response. These measurements can be followed during 
incremental exercise to determine the pattern of cardiac response to progressive exercise. 
This methodology has been utilized to determine the cardiovascular responses to 
progressive exercise in other pediatric populations including healthy children and patients 
with cardiac transplant, myocardial dysfunction, and oncology patients with previous 
anthracycline use [14-17].  
This study was designed to assess cardiovascular responses to progressive and 
maximal exercise in adolescent females with AN as compared to controls. To achieve 
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this, we used SSCE stress echocardiography and measured metabolic responses as well as 
indicators of myocardial function which have not been previously investigated in 
adolescent AN patients. To our knowledge, this is also the largest study of cardiovascular 
responses to exercise in adolescent females with AN.  
 
Methods 
Subjects: 
We performed a retrospective case-control study. The patient group consisted of 
female adolescents with AN who were referred by the Eating Disorders Program for 
stress echocardiography at the Children’s Heart Centre at the British Columbia Children’s 
Hospital between February 2004 and March 2012. The diagnosis of AN was made 
clinically by a multidisciplinary team including psychiatry and adolescent medicine and 
was based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) criteria [18]. Patients were studied during the acute phase of presentation and 
treatment for AN. If patients had more than one assessment, only the data from the 
complete initial assessment were used. The control group was composed of healthy 
adolescent female volunteers who were recruited from friends and family of hospital 
employees. The control subjects were physically active and most were involved in local 
team sports. The controls were of normal weight and did not have a history of AN. No 
control subjects were taking medications that would affect exercise performance. Height 
(cm), weight (kg), body mass index (BMI, kg/m2), and body surface area (BSA, m2) were 
recorded at the time of study. Ethics approval for this study was obtained from the 
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Children’s and Women’s Hospitals’ Research Ethics Board and the University of British 
Columbia’s Clinical Research Ethics Board. 
 
SSCE Stress Echocardiography 
Exercise testing was performed on an electronically braked, semi-supine cycle 
ergometer (Angio Ergometer and Echo Cardiac Stress Table, Lode BV, Groningen, 
Netherlands). Subjects were positioned with a torso angle of 45 degrees, with the heart 
approximately 15 cm above the level of the crank axis of the ergometer. Three minute 
stages of exercise were performed with initial and incremental workloads of 20 watts (W) 
per stage. Subjects were encouraged to exercise until volitional fatigue. The test was 
terminated when subjects were unable to sustain an appropriate pedaling rate to reach the 
target workload.  
Simultaneous HR, BP and echocardiography measurements were performed pre-
exercise and 90 seconds into each stage. Each echocardiographic data set took 60-90 
seconds to acquire.  Continuous 12-lead electrocardiogram (ECG) monitoring was 
performed throughout testing and HR was determined by the R-R interval on the ECG 
(Case 8000 Stress System, GE Medical Systems, Milwaukee, WI). Systolic (sBP) and 
diastolic (dBP) blood pressure was obtained in the right arm by auscultation. Muffling of 
the Korotkoff sounds defined the diastolic pressure. Peak exercise was defined as the final 
stage of exercise during which echocardiographic measurements were taken.  
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Echocardiography Protocol 
 Stress echocardiography was performed by an experienced pediatric 
echocardiographer using a Vivid 5 or Vivid 7 system (GE Vingmed Ultrasound, Horten, 
Norway). A 3.5MHz transducer was used for all studies. In the parasternal short-axis 
view, standard assessment of LV internal diameter was made at end-systole (LVESD) and 
end-diastole (LVEDD), with the LV posterior wall diameter measured at end-systole 
(LVPWDs) and end-diastole (LVPWDd) using two-dimensional (2D) targeted M-mode 
as per the American Society of Echocardiography [19]. The diameter of the aortic annulus 
was measured at the level of the valve leaflets using 2D echocardiography in the 
parasternal long-axis view. In a suprasternal long axis or apical four-chamber view, a 
pulsed wave Doppler recording of the ascending aorta was obtained by placing a sample 
volume in the center of the aorta at the level of the valve leaflets. The peak aortic velocity 
(PAoV), velocity-time integral (VTI), and ejection time (ET) were measured from this 
Doppler tracing. Measurements were made by the echocardiographer performing the 
study and a pediatric cardiologist.  
 
Calculations  
The amount of work (Joules) per stage was calculated as the product of workload 
(Watts) and the duration of exercise in a given stage (seconds) divided by the weight (kg). 
The total work was calculated as the summation of work performed per stage by the 
subject. The formulae for the calculation of the following variables are provided in Table 
3.1. We determined the meridonal wall stress at peak systole (σPS), or the tension within 
the wall of the LV during exercise, in both groups. LV contractility was calculated using 
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the fractional shortening (FS) and the rate corrected mean velocity of circumferential 
fiber shortening (MVCFc), which is an indicator of myocardial performance that is 
sensitive to changes in contractile state [20]. Total arterial compliance (TAC) and 
systemic vascular resistance (SVR) were also calculated with exercise as these are major 
determinants of cardiac afterload. Left ventricular mass (LVM) was calculated for 
patients and controls.  
 
VO2 methods 
In the latter half of the AN patients studied (n=39) and in all the controls, 
metabolic gas exchange parameters were measured using open-circuit spirometry by a 
metabolic cart (Moxus Metabolic Cart, AEI Technologies, Pittsburgh, PA). The metabolic 
cart was calibrated prior to each test using ambient air (20.93% O2 and 0.03% CO2) and 
calibration gas (15.0% O2 and 5.0% CO2). The calibration of the turbine flow meter of the 
volume sensor was performed with a standard 3L syringe. A calibration report was 
generated prior to each test.  
A small flexible rubber mouthpiece was attached to a one-way, non-rebreathing 
valve (Style 2700B, Hans Rudolph, Inc, Kansas City, MO) to the metabolic cart.  Breath-
by-breath data were collected and averaged over 15-second intervals during the test.  
Tidal volume (VT), breathing frequency (fb), minute ventilation (VE, L/min), oxygen 
consumption (VO2, L/min, mL/min/kg), carbon dioxide production (VCO2, L/min, 
mL/min/kg), ventilatory equivalents for oxygen and carbon dioxide (VE/VO2 and 
VE/VCO2) and respiratory exchange ratio (RER) were measured. Subjects were 
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encouraged to exercise until volitional fatigue. Arteriovenous oxygen difference (avO2) 
was calculated as (peak VO2)/(peak CO in deciliters/min). 
 
Body Size Indexing 
Body surface area was calculated using the DuBois formula BSA (m²) = 
0.20247(height)0.725(weight)0.425, with height measured in meters and weight in kilograms 
[21]. Standardization for body surface area (BSA) was performed by dividing the SV, 
CO, TAC, and LVM by the BSA to give the SVI, CI, TAC indexed (TACI), and LVM 
indexed (LVMI). CI was used in the formula to calculate SVR in order to obtain SVR 
indexed (SVRI). BMI percentiles were calculated for all subjects using data from the 
Centers for Disease Control growth data [22].  
 
Statistical Analysis 
Univariate analyses were performed on all continuous variables, and summary 
statistics are expressed as mean (SD). We compared the anthropometric parameters of 
AN and control groups using one-way ANOVA. The measured hemodynamic variables 
were compared within groups and between groups at resting and maximal exercise using 
one way ANOVA. In order to determine if degree of patient malnutrition affected 
exercise function, we divided the AN group into those with a BMI less than or equal to 
the 10th percentile (lowest BMI AN group) and those with a BMI greater than the 10th 
percentile (higher BMI AN group). These subgroups were compared to the control group 
using a one way ANOVA with post-hoc analysis performed using Tukey’s test. Pearson’s 
product-moment correlations were performed to investigate the relationship between 
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LVM and BMI percentile with exercise endurance. Multivariable linear regression was 
performed to determine if BMI percentile, age, VO2, peak CO, and LVM were 
independent predictors of exercise endurance in patients with AN.  
We considered p≤0.005 to indicate a statistically significant difference, p values 
of 0.005<p≤0.05 to be marginally statistically significant, and p values >0.05 to be non-
significant. All statistical analyses were performed using SPSS Statistics, version 17.0 
(SPSS Statistics for Windows, Version 17.0, SPSS Inc., Chicago). 
 
Graphical Presentation of Results 
 The mean values of HR, BP, SVI, CI, FS, MVCFc, σPS, SVRI, and TACI for the 
AN and control groups were graphed for each progressive stage of exercise. 
Hemodynamic and echocardiographic measures of cardiac function were only graphed for 
stages with > 20% of subjects remaining in order to avoid misrepresentation of responses 
to exercise due a low proportion of subjects remaining in the later exercise stages. Box 
plots comparing pre-exercise and peak exercise values for HR, BP, SVI, CI, FS, SVRI, 
and TACI were created to compare the AN and control groups. As the relationship of σPS 
and MVCFc represents a load independent measure of cardiac contractility [20, 23], the 
mean values for these variables at pre- and peak exercise for both the control and AN 
groups were plotted.  
 
Results 
Clinical Characteristics 
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There were a total of 66 adolescent females in the AN group and 21 healthy 
adolescent female controls. Twelve of the AN patients were classified as the binge-purge 
subtype and 54 were the restrictive subtype. The baseline characteristics for the AN and 
control groups are provided in Table 3.2. The patients with AN were significantly older 
than control patients (15.6 vs 14.4 years) with no difference in height between groups. 
AN patients had a significantly decreased weight, BSA, BMI, BMI percentile, LVM, and 
LVMI compared to control subjects.  
The AN subgroups with BMI ≤ 10th percentile and >10th percentile were 
composed of 39 patients with 27 patients respectively. Neither group had significant 
differences in age or height when compared to the control group. The BMI ≤ 10th 
percentile group had significantly decreased weight, BSA, BMI, BMI percentile, LVM, 
and LVMI compared to controls. The only significant differences between the BMI >10th 
percentile AN group and controls were decreased weight, BMI percentile, and LVM.  
 
Exercise Performance 
 Figure 3.1 demonstrates the number and percentage of subjects remaining in each 
stage for the AN and control groups. Table 3.3 outlines the exercise performance of the 
groups. Patients with AN had decreased exercise duration compared to controls, and AN 
patients with a BMI ≤ 10th percentile had a decreased exercise capacity compared to 
those with a BMI > 10th percentile (12.7 vs 15.3 min, p = 0.043). Exercise duration 
correlated with BMI percentile (r=0.524, p<0.001), LVMI (r=0.580, p<0.001), peak VO2 
(r=0.745, p<0.001), and peak CI (r=0.451, p<0.001), but not age (p=0.156). Multiple 
linear regression was performed using test duration as the dependent variable with age, 
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BMI percentile, peak CO, peak VO2, and LVM as independent variables to determine 
which variables were independent predictors of exercise duration in patients with AN. 
The assumptions of linearity, independence of errors, homoscedasticity, unusual points 
and normality of residuals were met. The model was statistically significant and 
explained a large amount of the variability in exercise test duration, F(5,41)=49.374, 
p<0.001, adj R2=0.840. BMI percentile, age, peak VO2, and peak CO were significant 
independent predictors of exercise duration. Regression coefficients are provided in Table 
3.4.  
 Total work, peak VE, and peak VO2 were significantly decreased in AN patients 
and in the AN subgroups compared to controls. Mean peak RER was greater than 1.0 for 
all groups, indicating that these groups achieved a maximal test. RER was significantly 
greater for the total AN and BMI ≤ 10th percentile groups than in controls. There were no 
differences between patients with AN and controls in avO2 difference. 
 All subjects were asymptomatic during exercise with no episodes of chest pain, 
unusual breathlessness, or dizziness. There were no arrhythmias or ischemic changes in 
the ECG with exercise.  
 
Cardiovascular Responses to Exercise  
 Table 3.5 summarizes the hemodynamic parameters at pre- and peak exercise for 
patients with AN and controls. Figure 3.2 demonstrates the response of HR, sBP, and dBP 
to progressive exercise in patients with AN and controls and provides a graphical 
representation of the pre- and peak exercise values for these groups. HR was similar 
between groups while sBP and dBP were lower in patients with AN compared to controls 
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at pre-exercise. HR increased similarly in both groups with progressive exercise, 
however, was decreased in AN patients at peak exercise. sBP and dBP were decreased in 
AN patients at pre- and peak  exercise, although the pattern of increase with progressive 
exercise in AN patients was parallel to controls. In both groups, sBP increased steadily 
with exercise while dBP demonstrated a minimal, although statistically significant, 
increase. The differences in pre- and peak exercise values for HR, sBP, and dBP 
remained present when the AN patients were stratified into those with a BMI ≤ and > 
10th percentile.  
 Table 3.6 summarizes the echocardiographic measurements and measures of 
ventricular function at pre- and peak exercise for the AN and control groups. LVEDD and 
LVESD were significantly smaller in AN patients at pre-exercise with no difference at 
peak exercise, although these differences were no longer apparent once LVEDD and 
LVESD were indexed to BSA (Table 3.6). After stratification according to BMI 
percentile, only patients with a BMI ≤ 10th percentile had a decreased LVEDD at pre-
exercise compared to controls. 
 As demonstrated in Table 3.4, there were no differences in SV or SVI between 
AN and control groups at either pre- or peak exercise, although the SV trended towards 
being significantly decreased at peak exercise in AN patients. AN patients had similar CO 
and CI pre-exercise and significantly decreased CO and CI at peak exercise when 
compared to controls. These differences remained after stratification for BMI in both the 
lower and higher BMI AN patient subgroups. As seen in Figure 3.3, SVI initially 
increased and subsequently plateaued in the higher exercise stages for both the AN and 
control groups, with a virtually identical pattern of response to progressive exercise in 
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both groups. CI increased in a linear fashion with increasing exercise stage in both AN 
and control groups with a similar pattern of response between the groups.   
 Figure 3.4 demonstrates a similar pattern of increase in FS and MVCFc with 
progressive exercise between AN and control groups. Both FS and MVCFc were similar 
between groups pre-exercise but were significantly decreased in AN patients at peak 
exercise, with this difference persisting in AN patients with BMI ≤ 10th percentile after 
group stratification by BMI percentile (Table 3.6). The patterns of increase in FS and 
MVCFc with progressive exercise were similar between the AN and control groups, as 
seen in Figure 3.4. Table 3.6 demonstrates a significant decrease in σPS in AN patients 
compared to controls at pre-exercise, which was also seen in both the lower and higher 
weight AN patients after stratification by BMI percentile. The total group of AN patients 
had a lower σPS than controls at peak exercise, which did not reach statistical 
significance in either the AN subgroups of BMI ≤ or > 10th percentile (Table 3.6).  There 
was an appropriate decrease in σPS with progressive exercise in the control group while 
σPS showed little change with progressive exercise in the AN group (Figure 3.4).  Figure 
3.5 demonstrates a similar and appropriate response in the MVCFc-σPS relationship from 
pre- to peak exercise in the AN and control groups.  
 As outlined in Table 3.5, SVR and SVRI were lower in the AN group at pre-
exercise with no difference at peak exercise when compared to controls. After stratifying 
for BMI percentile, both the BMI ≤ and > 10th percentile AN groups has a decrease in 
SVRI at pre-exercise with no other differences from controls in SVR or SVRI.  Figure 3.6 
demonstrates that SVRI decreases initially with exercise and begins to plateau in the latter 
exercise stages in both the AN and control groups. Mean TAC values for the AN group 
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were similar at pre-exercise and significantly increased at peak exercise when compared 
to controls (Table 3.5). After indexing for BSA, TACI was significantly increased at pre- 
and peak exercise compared to controls for the total AN group and AN patients ≤10th 
percentile. These differences between the AN and controls groups in TAC trended 
towards significance for the AN patents with BMI > 10th percentile. As seen in Figure 
3.6, TACI decreased with progressive exercise in both AN and control groups.  
 
Discussion 
 To our knowledge, this is the largest study investigating exercise performance in 
adolescent females with AN. This study also investigates echocardiographic measures of 
cardiac function with exercise which have not been previously performed in adolescent 
females with AN. Our study demonstrates that adolescent females with AN have 
decreased exercise capacity compared to controls. Although the hemodynamic and 
echocardiographic function values at peak exercise were decreased in AN patients for the 
majority of measured indices, the patterns of response to progressive exercise for these 
variables were similar to controls.  
Our study demonstrated that the responses of HR, SVI, CI, FS, and MVCFc to 
progressive exercise in patients with AN mirrors those of controls. However, the values 
of HR, CI, FS, and MVCFc at peak exercise were significantly decreased in patients with 
AN. The parallel patterns of response to progressive exercise in patients and controls 
suggests that myocardial function is not likely the primary limiting factor to exercise 
performance in females with AN. One possible explanation for the decrease in the peak 
exercise values for cardiac hemodynamic responses and cardiac contractility in patients 
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with AN may be due to patients not being able to sustain exercise and achieve the same 
workload as controls. Despite the difference in the pattern of response to progressive 
exercise for σPS between the patients with AN and controls, we found a similar pattern of 
response to exercise in both the control and AN patients in the MVCFc-σPS relationship, 
which is reported to be a preload-independent and afterload adjusted indicator of systolic 
function in the absence of ventricular outlet obstruction [20, 23]. The normal response of 
the MVCFc-σPS relationship with exercise further suggests normal cardiac contractility 
with exercise in patients with AN. We also assessed the effect of progressive exercise on 
left ventricular afterload as reflected by SVR and TAC, which both decrease with 
progressive exercise in normal subjects [15, 24], and found similar decreases in TACI and 
SVRI with progressive exercise in both groups. Responses of hemodynamic variables to 
progressive exercise in AN were also investigated by Rowland et al. (2003) [13]. We 
confirmed their results of similar pattern of increase in SVI with exercise in AN and 
control patients, although they reported an increased peak SVI in patients with AN, which 
differs from the results of our study [13]. Our results do not suggest the presence of 
myocardial dysfunction during exercise in patients with AN as the patterns we 
documented differ from the reported pattern of response to progressive exercise in 
pediatric patients with known myocardial dysfunction, who show divergences from 
control values in stroke volume with progressive exercise [16].  
Exercise endurance was significantly decreased in the patients with AN compared 
to controls, and was lower in AN patients with BMI ≤ 10th percentile than those with a 
BMI > 10th percentile. These findings are suggestive that increased levels of 
malnourishment are associated with decreased exercise performance. The finding of 
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increased level of malnourishment predicting decreased exercise duration was 
strengthened by our multiple linear regression analysis which demonstrated that BMI 
percentile is an independent predictor of exercise duration in patients with AN. Decreased 
exercise endurance or decreased work has also been reported in multiple studies of 
patients with AN [7, 11, 12, 25].  Previous studies have also demonstrated a correlation 
between a subject’s BMI or percent of ideal body weight with maximum work or exercise 
duration [25, 26].  The decrease in exercise capacity in the setting of more severe 
malnourishment may be secondary to increased deconditioning, decreased skeletal muscle 
mass, partial atrophy of selected muscular fibers, or to muscular dysfunction from 
decreased energy stores available for utilization by skeletal muscle during exercise, 
alterations in intracellular micronutrients, defects in ion channel function, or slowing of 
muscular relaxation rate [26, 27]. Skeletal muscle mass and function have been shown to 
be decreased in the setting of AN. Muscle biopsies in patients with AN have 
demonstrated atrophy of muscle fibers with type II fibers being the most affected [28-31]. 
Total muscle mass and muscle mass per kg of body weight is lower in patients with AN 
than controls [32].  Slowed muscle relaxation, increased muscle fatigue, and decreased 
maximum voluntary contraction forces have all been demonstrated in patients AN, with 
some improvements in muscle function after refeeding [27, 30]. With nutritional 
repletion, the majority of the weight regained is represented by fat, with gains in muscle 
mass lagging behind [32].  Despite the lag in regaining muscle mass, significant 
improvements in leg muscle performance and exercise endurance after refeeding have 
been demonstrated in patients with AN, which suggests that skeletal muscle dysfunction 
associated with malnutrition is a significant contributor of decreased exercise 
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performance in AN [26]. Cardiac muscle mass is also decreased in the setting of AN, 
which was confirmed in our study where the LVM and LVMI were decreased in AN 
patients compared to controls [3, 4, 6, 8, 9, 33]. Our multiple linear regression model 
demonstrated that LVM was not an independent predictor of exercise duration, suggesting 
that the decrease in cardiac mass seen in patients with AN does not significantly 
contribute to the decreased exercise capacity in this population. The multiple linear 
regression model explained a large amount of the variability in exercise duration, with the 
remainder of the variability possibly explained by other factors such as pre-existing level 
of physical activity, which was not quantified by our study,  
Our AN patients had decreased aerobic fitness compared to controls as evidenced 
by decreased peak VO2, which reached 79% of the peak value for controls. Despite the 
fact that VO2 is indexed for weight, which should have conferred an advantage to the AN 
population as their weight was significantly lower than that of controls, the VO2 remained 
decreased in the AN group. Several other studies have demonstrated a decreased peak 
VO2 in the AN population [7, 12, 13, 26, 34-38]. We found a peak VO2 value of 31.3 
mL/kg/min in the AN group, which is comparable to previously reported values for 
females with AN [11, 13, 34-36]. VO2 is the maximal oxygen consumption which is 
determined by the product of CO and avO2 difference, or the oxygen extraction at the 
level of the muscle. As there was no difference in the peak avO2 between the AN and 
control groups, a decrease in the peak CO is responsible for the decreased VO2 in the AN 
population. CO is determined by the product of HR and SV. Our study demonstrated no 
difference in the SV at peak exercise between the two groups, but demonstrated a 
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significant decrease in the peak HR, making a decreased peak HR the major contributor 
of decreased CO and subsequently decreased peak VO2 in our study subjects.  
Although CI followed the same pattern with progressive exercise in patients with 
AN and controls, peak CO and CI were decreased in AN patients at peak exercise. 
Studies of exercise in patients with AN have demonstrated conflicting results regarding 
peak CO as well as the relative contribution of HR and SV to CO. Lands et al. (1992) 
demonstrated that although patients with AN were not able to perform as much work as 
controls with steady state exercise, their CO was appropriate for the amount of work 
performed, which was achieved by relatively faster HR but lower SV than predicted [25]. 
However, these patients were exercising at 50% of their peak workload and this may not 
be generalizable to CO at peak workloads. In contrast, in a study comparing 8 adolescents 
with AN and controls, Rowland et al. (2003) demonstrated similar CO between the 
groups which was caused by an increased peak SVI and decreased HR in the AN patients 
[13].  
The decreased peak HR demonstrated by our study is consistent with findings in 
AN patients with  exercise testing [7, 10-13, 34]. Nudel et al. (1984) found a depressed 
peak HR in adolescents with AN and an associated decrease in norepinephrine and 
dopamine levels [11].  These authors also found that AN patients with increased 
norepinephrine levels had significantly higher peak HR than AN patients with lower 
norepinephrine levels, although the peak HR was still less than that of controls [11]. 
Nudel et al. (1984) speculated that decreased cathecholamine levels partially explain the 
decreased peak HR in AN, but is not the only factor as the peak HR remains depressed in 
the setting of normal catecholamine levels [11]. Our study demonstrated that at a given 
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workload, the HR of AN patients and controls were similar. These findings are in contrast 
to those of St John Sutton et al. (1985) who demonstrated decreased HR in patients with 
AN compared to controls for a given workload [7]. Other authors have suggested that 
although the absolute peak HR is decreased in AN patients, the HR expressed as a percent 
expected for work reveals an appropriate HR response or a relative tachycardia in patients 
with AN, which is consistent with our findings [25].  
Although we have demonstrated that females with AN have decreased VO2 and 
exercise capacity, our findings of parallel indices of myocardial function suggests that 
myocardial function in response to exercise is normal in this patient population. Other 
studies have also suggested that myocardial performance is not the primary limiting factor 
in patients with AN to sustain exercise. Rowland et al. (2003) concluded that myocardial 
performance in patients with AN during exercise was normal, as measured by peak aortic 
velocity and average flow acceleration in the aorta when related to HR [13]. Lands et al. 
(1992) concluded that the diminished exercise capacity demonstrated in AN was likely 
caused by diminished skeletal muscle mass or muscle dysfunction rather than by cardiac 
insufficiency [25]. Gottdiener et al. (1978) demonstrated an appropriate increase in 
ejection fraction with supine bicycle exercise measured by radionuclide cineangiograms 
[10]. Our study is in agreement with the literature supporting normal patterns of 
myocardial response to exercise in patients with AN.  
There were no adverse events associated with exercise testing in our patients or 
controls and no evidence of ischemia on the ECGs taken during exercise testing. Previous 
studies have, however, demonstrated ECG changes during exercise in patients with AN. 
Nudel et al. (1984) demonstrated significant ST depression in 25% of the AN patients 
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who had exercise testing performed [11]. Rowland et al. (2003) reported “scooping” of 
the ST segments in one AN patient who also had decreased FS on the resting 
echocardiogram [13]. Rigaud et al (1997) terminated an exercise test in one patient at the 
first exercise test after hospital admission due to an arrhythmia [26]. Our study suggests 
that exercise was safe in the patients that were studied, however, there exists a potential 
for electrocardiographic changes in the setting of AN during exercise as evidenced by 
previous studies. It is possible that the patients in our study population had lesser disease 
severity than those patients demonstrating ECG changes in previous studies.  
Limitations of our study include the retrospective nature of the study and the 
inherent biases associated with this design. Patients were studied during the acute phase 
of treatment for AN and were likely at variable stages of their nutritional rehabilitation at 
the time of study, which may have influenced the results obtained as it has been shown 
that refeeding improves exercise performance [26]. Patients in our study were exercised 
in a semi-supine position on a cycle ergometer, which requires sufficient leg strength to 
overcome the resistance provided by the ergometer. Deconditioning and loss of muscle 
mass in the AN patients may have led to insufficient strength to overcome resistance on 
the ergometer and led to a decrease in total work. Performing the exercise test in the 
upright position on a treadmill may have allowed the AN patients to attain higher peak 
exercise values including heart rate and VO2, however, would not have allowed for the 
echocardiographic measurements obtained by our study to be taken. Use of a 20 Watt 
incremental workload in our study protocol yielded an exercise test of appropriate 
duration in the majority of our AN patients, but resulted in long exercise times in our 
control subjects, making these assessments tests of endurance. Excessive exercise is 
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known to prevalent in patients with AN and there may be different cardiovascular 
responses between patients who exercise excessively and those who do not [39]. We were 
not able to quantify the amount of exercise performed by patients with AN prior to their 
diagnosis and thus were not able to assess the influence of this factor in our study. Our 
study only indexed the variables to BSA but it is unclear if indexing values using BSA is 
the most appropriate means to account for the effect of body dimension in patients with 
AN [13]. However, it has been shown by Rowland et al. (2003) that indexing by either 
BSA or lean body mass did not alter the conclusions of the study [13]. The number of 
controls in our study was fewer than the number of patients due to the difficulty of 
recruiting healthy adolescent female volunteers to undergo echocardiography. It is 
possible that an increased number of controls could have demonstrated additional 
significant differences between the patient and control groups. Lastly, we were unable to 
determine ventricular diastolic function with exercise and cannot exclude the possibility 
of diastolic dysfunction occurring with exercise in this patient population.  
Further study is required to determine the response of the cardiac hemodynamic 
variables and echocardiographic indices of left ventricular function with weight 
restoration in patients with AN. Several studies have demonstrated an improvement in 
peak VO2, exercise duration, maximal HR, and workload achieved with refeeding in AN 
[26, 36, 37, 40, 41], but no studies have demonstrated if there are changes in the response 
of FS, MVCFc, σPS, TAC, or SVR with exercise after refeeding. The mechanism of 
decreased exercise capacity in patients with AN and the relative contributions of 
deconditioning, deceased muscle mass, impaired muscular function, and impaired 
cathecholamine response has not been clarified and would require further investigation. 
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This study was not designed to establish the earliest it is safe to exercise in the most 
severely affected patients with AN, and this has yet to be determined.  
In conclusion, adolescent patients with AN appear to have normal patterns of 
cardiovascular response to progressive exercise although values at pre- and peak exercise 
may differ from controls. Despite these normal responses to progressive exercise, 
exercise capacity is reduced. After controlling for age, exercise endurance is 
independently predicted by BMI percentile. Our study suggests that systolic ventricular 
function in adolescents with AN is not likely to be the limiting factor in their ability to 
exercise.  
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Table 3.1 Formulae for calculating the echocardiographic parameters 
Parameter Formula 
AoCSA 
(cm2) 
(π/4) (aortic annulus diameter)2 
SV 
(mL) 
VTI · AoCSA 
CO 
(L/min) 
HR · SV/1000 
PP 
(mmHg) 
sBP-dBP 
MAP 
(mmHg) 
(sBP + 2*dBP)/3  
FS 
(%) 
100*(LVEDD-LVESD)/LVEDD 
TAC 
(mL/mmHg) 
SV/PP 
SVR 
(Wood units) 
MAP/CO 
ETc 
(s) 
ET/√RR 
MVCFc 
(circ/s) 
(LVEDD-LVESD)/(ETc/1000*LVEDD) 
σPS 
(g/cm2) 
0.34*sBP*LVESD/LVPWDs*(1+(LVPWDs/LVESD)) 
LVM  
(g) 
1.05[(LVEDD + 2*LVPWDd)3-LVEDD3] 
AoCSA = aortic cross-sectional area, SV = stroke volume, VTI = velocity time integral, 
CO = cardiac output, HR = heart rate, PP = pulse pressure, sBP = systolic blood pressure, 
dBP = diastolic blood pressure, MAP = mean aortic pressure, FS = fractional shortening, 
LVEDD = left ventricular end-diastolic diameter, LVESD = left ventricular end-systolic 
diameter, TAC = total arterial compliance, SVR = systemic vascular resistance, ETc = 
envelope time corrected, ET = envelope time, RR = R-R interval, MVCFc = rate 
corrected mean velocity of circumferential fiber shortening, σPS = stress at peak systole, 
LVPWDs = left ventricular posterior wall diameter in systole, LVM = left ventricular 
mass, LVPWDd = left ventricular posterior wall diameter in diastole 
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Table 3.2:  Baseline Characteristics of all Patients with AN and AN Subgroups Compared 
to Control Subjects 
  
Control Group 
(n = 21) 
 
Total AN 
Group* 
(n = 66) 
AN Subgroups§ 
BMI ≤10th 
percentile 
(n=39) 
BMI>10th 
percentile 
(n=27) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Age (years) 14.4 (1.9) 15.6 (1.9) 
p = 0.015 
15.6 (1.8) 
p = 0.051 
15.5 (2.1) 
p = 0.118 
Height (cm) 162.5 (7.9) 161.0 (9.1) 
p = 0.482 
162.7 (6.9) 
p = 0.996 
158.4 (11.3) 
p = 0.240 
Weight (kg) 52.3 (9.0) 43.4 (7.3) 
p < 0.001 
41.0 (5.6) 
p < 0.001 
46.9 (7.9) 
p = 0.037 
BSA (m2) 1.54 (0.15) 1.42 (0.15) 
p = 0.001 
1.40 (0.12) 
p = 0.001 
1.45 (0.18) 
p = 0.080 
BMI (kg/m2) 19.7 (2.6) 16.7 (2.1) 
p < 0.001 
15.4 (1.4) 
p < 0.001 
18.6 (1.3) 
p = 0.061 
BMI percentile 48.1 (27.4) 12.6 (15.5) 
p < 0.001 
1.9 (2.1) 
p < 0.001 
28.1 (13.2) 
p < 0.001 
LVM (g) 140.4 (33.0) 105.5 (29.3) 
p < 0.001 
98.8 (21.1) 
p < 0.001 
72.0 (13.5) 
p = 0.005 
LVMI (g/m2) 87.6 (17.3) 76.5 (17.6) 
p = 0.017 
116.1 (37.2) 
p = 0.032 
83.6 (21.1) 
p = 0.732 
AN= Anorexia nervosa, SD = standard deviation, BSA = body surface area, BMI = body 
mass index, LVM = left ventricular mass, LVMI = left ventricular mass indexed 
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
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Table 3.3:  Exercise Performance Characteristics of all Patients with AN and AN 
Subgroups Compared to Control Subjects 
  
Control Group 
(n=21) 
 
Total AN 
Group* 
(n=66) 
AN Subgroups§ 
BMI ≤10th 
percentile 
(n=39) 
BMI>10th 
percentile 
(n=27) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Test duration 
(min) 
20.8 (4.1) 13.8 (4.5) 
p <0.001 
12.7 (4.4) 
p <0.001 
15.3 (4.1) 
p <0.001 
Total work  
(J/kg) 
1914 (498) 1125 (558) 
p <0.001 
1046 (589) 
p <0.001 
1241 (496) 
p <0.001 
Peak VE 
(L/min) 
72.0 (14.4) 47.4 (18.3) 
p <0.001 
47.0 (21.1) 
p <0.001 
48.0 (14.8) 
p <0.001 
Peak VO2 
(mLO2/kg/min) 
39.7 (6.8) 31.3 (8.3) 
p = 0.001 
31.4 (9.2) 
p = 0.003 
31.1 (7.3) 
p = 0.004 
Peak RER 1.06 (0.07) 1.14 (0.10) 
p = 0.002 
1.16 (0.10) 
p = 0.002 
1.12 (0.09) 
p = 0.091 
Peak avO2  
(mLO2/100mL 
of blood) 
0.204 (0.053) 0.185 (0.065) 
p = 0.262 
0.172 (0.053) 
p = 0.217 
0.201 (0.077) 
p = 0.987 
AN= Anorexia nervosa, SD = standard deviation, BMI = body mass index, VE = minute 
ventilation, VO2 = maximal oxygen consumption, RER = respiratory exchange ratio, 
avO2 = arteriovenous oxygen difference 
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
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Table 3.4 Summary of Multiple Linear Regression Analysis for Patients with AN (n=47) 
Predictor Variable B (95% CI) β  t p value 
BMI percentile 4.4 (2.5-6.3) 0.354 4.736 <0.001 
Age  45.7 (18.8-72.6) 0.252 3.431 0.001 
Peak VO2 25.2 (19.4-30.9) 0.620 8.850 <0.001 
Peak CO 27.9 (19.4-30.9) 0.244 2.385 0.022 
LVM 0.3 (-1.7 – 2.3) 0.027 0.280 0.781 
B = unstandardized coefficient, β = standardized coefficient, t = t statistic, BMI = body 
mass index, VO2 = oxygen consumption, CO = cardiac output, LVM = left ventricular 
mass 
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Table 3.5:  Hemodynamic Variables at Pre- and Peak Exercise for all Patients with AN 
and AN Subgroups Compared to Control Subjects 
   
Control 
Group 
(n=21) 
 
Total AN 
Group* 
(n=66) 
AN Subgroups§ 
 BMI ≤10th 
percentile 
(n=39) 
BMI>10th 
percentile 
(n=27) 
  Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
HR 
(beats/min) 
Pre-
exercise 
73.4 (11.2) 
 
74.0 (14.1) 
p = 0.859 
72.5 (12.3) 
p = 0.966 
76.2 (16.4) 
p = 0.757 
Peak 
exercise 
186.8 (7.6) 156.7 (19.5) 
p < 0.001 
154.0 (19.7) 
p < 0.001 
160.3 (19.0) 
p < 0.001 
sBP 
(mmHg) 
Pre-
exercise 
119.0 (9.4) 97.4 (10.2) 
p < 0.001 
95.3 (9.9) 
p < 0.001 
100.6 (10.0) 
p < 0.001 
Peak 
exercise 
195.0 (17.6) 144.0 (20.8) 
p < 0.001 
138.2 (19.4) 
p < 0.001 
152.4 (20.2) 
p < 0.001 
dBP 
(mmHg) 
Pre-
exercise 
73.0 (6.1) 59.1 (7.1) 
p < 0.001 
56.9 (6.4) 
p < 0.001 
62.3 (7.1) 
p < 0.001 
Peak 
exercise 
81.3 (9.7) 65.4 (10.6) 
p < 0.001 
64.0 (11.5) 
p < 0.001 
67.5 (9.1) 
p < 0.001 
SV 
(mL) 
Pre-
exercise 
47.1 (11.3) 44.6 (11.3) 
p = 0.387 
44.4 (10.6) 
p = 0.658 
45.0 (12.3) 
p = 0.796 
Peak 
exercise 
57.0 (13.3) 50.3 (13.7) 
p = 0.053 
50.1 (11.9) 
p = 0.157 
50.6 (16.1) 
p = 0.247 
SVI 
(mL/m2) 
 
Pre-
exercise 
30.3 (6.5) 
 
31.4 (6.9) 
p = 0.536 
31.8 (7.2) 
p = 0.694 
30.7 (6.5) 
p = 0.977 
Peak 
exercise 
36.8 (7.0) 35.3 (8.2) 
p = 0.477 
36.9 (7.9) 
p = 0.911 
34.6 (8.7) 
p = 0.619 
CO 
(L/min) 
 
Pre-
exercise 
3.44 (0.93) 3.24 (0.78) 
p = 0.331 
3.19 (0.80) 
p = 0.492 
3.32 (0.77) 
p = 0.863 
Peak 
exercise 
10.61 (2.46) 7.80 (2.12) 
p < 0.001 
7.64 (1.93) 
p < 0.001 
8.03 (2.39) 
p < 0.001 
CI 
(L/min/m2) 
Pre-
exercise 
2.23 (0.56) 2.30 (0.54) 
p = 0.640 
2.29 (0.55) 
p = 0.923 
2.31 (0.54) 
p = 0.886 
 Peak 
exercise 
6.86 (1.34) 5.50 (1.32) 
p < 0.001 
5.49 (1.28) 
p = 0.001 
5.51 (1.41) 
p = 0.002 
SVR 
(Wood 
Pre-
exercise 
27.4 (7.8) 23.5 (6.5) 
p = 0.026 
23.1 (5.8) 
p = 0.058 
24.2 (7.6) 
p = 0.237 
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units) Peak 
exercise 
8.7 (1.9) 9.9 (2.8) 
p = 0.076 
9.6 (2.6) 
p = 0.406 
10.3 (3.2) 
p = 0.111 
SVRI 
(Wood 
units·m2) 
Pre-
exercise 
42.2 (12.5) 33.3 (9.5) 
p = 0.001 
32.2 (8.3) 
p = 0.002 
34.8 (11.0) 
p = 0.041 
Peak 
exercise 
18.1 (4.1) 17.6 (4.8) 
p = 0.660 
16.9 (4.6) 
p = 0.625 
18.5 (4.9) 
p = 0.952 
TAC 
(mL/mmHg
) 
Pre-
exercise 
1.05 (0.31) 1.21 (0.40)  
p = 0.085 
1.19 (0.34) 
p = 0.331 
1.24 (0.49) 
p = 0.200 
Peak 
exercise 
0.51 (0.13) 0.68 (0.27) 
p = 0.006 
0.71 (0.24) 
p = 0.010 
0.64 (0.32) 
p = 0.156 
TACI 
(mL/mmHg
/m2) 
Pre-
exercise 
0.68 (0.21) 0.85 (0.26) 
p = 0.008 
0.86 (0.25) 
p = 0.028 
0.84 (0.27) 
p = 0.075 
Peak 
exercise 
0.33 (0.08) 0.48 (0.19) 
p = 0.001 
0.51 (0.18) 
p < 0.001 
0.44 (0.20) 
p = 0.074 
AN= Anorexia nervosa, SD = standard deviation, BMI = body mass index, HR = heart 
rate, sBP = systolic blood pressure, dBP = diastolic blood pressure, SV = stroke volume, 
SVI = stroke volume index, CO = cardiac output, CI = cardiac index, SVR = systemic 
vascular resistance, SVRI = systemic vascular resistance indexed, TAC = total arterial 
compliance, TACI = total arterial compliance indexed  
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
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Table 3.6:  Echocardiographic Dimensions and Myocardial Performance at Pre- and Peak 
Exercise for all Patients with AN and AN Subgroups Compared to Control Subjects 
   
Control 
Group 
(n=21) 
 
Total AN 
Group* 
(n=66) 
AN Subgroups§ 
 BMI ≤10th 
percentile 
(n=39) 
BMI>10th 
percentile 
(n=27) 
  Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
LVEDD  
(cm) 
Pre-
exercise 
4.64 (0.36) 4.37 (0.40) 
p = 0.007 
4.33 (0.37) 
p = 0.011 
4.43 (0.45) 
p = 0.162 
Peak 
exercise 
4.47 (0.40) 4.31 (0.42) 
p = 0.143 
4.27 (0.42) 
p = 0.186 
4.38 (0.41) 
p = 0.729 
LVESD  
(cm) 
Pre-
exercise 
2.93 (0.28) 2.75 (0.33) 
p = 0.030 
2.73 (0.29) 
p = 0.062 
2.79 (0.38) 
p = 0.284 
Peak 
exercise 
2.15 (0.29) 2.22 (0.28) 
p = 0.364 
2.23 (0.25) 
p = 0.555 
2.19 (0.32) 
p = 0.857 
LVEDD 
indexed 
(cm/m2) 
Pre-
exercise 
3.02 (0.25) 3.11 (0.34) 
p = 0.295 
3.13 (0.35) 
p = 0.467 
3.08 (0.33) 
p = 0.814 
Peak 
exercise 
2.94 (0.29) 3.07 (0.35) 
p = 0.130 
3.08 (0.35) 
p = 0.283 
3.05 (0.37) 
p = 0.481 
LVESD 
indexed 
(cm/m2) 
Pre-
exercise 
1.91 (0.18) 1.96 (0.24) 
p = 0.381 
1.97 (0.24) 
p = 0.529 
1.93 (0.23) 
p = 0.920 
Peak 
exercise 
1.41 (0.21) 1.58 (0.22) 
p = 0.005 
1.61 (0.20) 
p = 0.004 
1.53 (0.24) 
p = 0.173 
LVPWDs 
(cm) 
Pre-
exercise 
1.11 (0.08) 1.04 (0.09) 
p = 0.004 
1.03 (0.09) 
p = 0.009 
1.05 (0.09) 
p = 0.088 
 Peak 
exercise 
1.35 (0.08) 1.22 (0.10) 
p < 0.001 
1.19 (0.10) 
p < 0.001 
1.26 (0.09) 
p = 0.004 
FS 
(%) 
Pre-
exercise 
36.8 (3.6) 36.9 (4.1) 
p = 0.897 
36.8 (4.2) 
p = 0.999 
37.1 (3.9) 
p = 0.971 
Peak 
exercise 
51.9 (4.1) 48.7 (4.0) 
p = 0.002 
47.7 (3.7) 
p = 0.001 
50.1 (4.0) 
p = 0.256 
MVCFc 
(circ/s) 
Pre-
exercise 
1.22 (0.12) 1.17 (0.15) 
p = 0.234 
1.18 (0.18) 
p = 0.654 
1.16 (0.10) 
p = 0.383 
 Peak 
exercise 
1.62 (0.19) 1.50 (0.23) 
p = 0.030 
1.46 (0.20) 
p = 0.022 
1.55 (0.26) 
p = 0.509 
σPS 
(g/cm2) 
Pre-
exercise 
78.5 (12.9) 64.5 (14.5) 
p < 0.001 
62.9 (14.0) 
p < 0.001 
66.8 (15.1) 
p = 0.016 
134 
 Peak 
exercise 
64.3 (9.5) 57.4 (12.9) 
p = 0.030 
57.4 (13.5) 
p = 0.115 
57.4 (12.3) 
p = 0.142 
AN= Anorexia nervosa, SD = standard deviation, BMI = body mass index, LVEDD = left 
ventricular end-diastolic diameter, LVESD = left ventricular end-systolic diameter, FS = 
fractional shortening, MVCFc = rate corrected mean velocity of circumferential fiber 
shortening, σPS = stress at peak systole,  
*p values determined using one- way ANOVA comparing AN group to controls 
§ p values determined using Tukey’s test for post-hoc ANOVA analysis comparing AN 
subgroups to controls 
  
135 
 
Figure 3.1: The remaining (A.) number and (B.) percentage of anorexia nervosa (AN) and 
control subjects per stage of exercise.  Stage 0 is the pre-exercise stage, with each 
incremental increase in stage number representing a 20 Watt increase in workload. 
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Figure 3.2: Response of (A.) heart rate, (B.) systolic blood pressure (BP), and (C.) 
diastolic BP to progressive exercise in patients with anorexia nervosa (AN) and controls. 
The error bars indicate the standard error of the mean. Stage 0 is the pre-exercise stage, 
with each incremental increase in stage number representing a 20 Watt increase in 
workload. Box plots comparing  the mean values for (D.) heart rate, (E.) systolic BP, and 
(F.) diastolic BP at pre- and peak exercise for the AN and control groups are provided. 
Significant differences (p<0.05) between values at pre-exercise and peak exercise for 
either the AN or control groups are indicated by the * symbol. Significant differences 
(p<0.05) between the control and AN groups for either pre-exercise or peak exercise 
values are indicated by the § symbol.  
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Figure 3.3: Response of (A.) stroke volume indexed (SVI) and (B.) cardiac index (CI) to 
progressive exercise in patients with anorexia nervosa (AN) and controls. The error bars 
indicate the standard error of the mean. Stage 0 is the pre-exercise stage, with each 
incremental increase in stage number representing a 20 Watt increase in workload. Box 
plots comparing  the mean values for (C.) SVI and (D.) CI at pre- and peak exercise for 
the AN and control groups are provided. Significant differences (p<0.05) between values 
at pre-exercise and peak exercise for either the AN or control groups are indicated by the 
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* symbol. Significant differences (p<0.05) between the control and AN groups for either 
pre-exercise or peak exercise values are indicated by the § symbol. 
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Figure 3.4: Response of (A.) fractional shortening, (C.) mean velocity of circumferential 
fiber shortening (MVCFc), and (D.) stress at peak systole (σPS) to progressive exercise in 
patients with anorexia nervosa (AN) and controls. The error bars indicate the standard 
error of the mean. Stage 0 is the pre-exercise stage, with each incremental increase in 
stage number representing a 20 Watt increase in workload. A box plot comparing the 
mean values for (B.) fractional shortening at pre- and peak exercise for the AN and 
control groups is provided. Significant differences (p<0.05) between values at pre-
exercise and peak exercise for either the AN or control groups are indicated by the * 
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symbol. Significant differences (p<0.05) between the control and AN groups for either 
pre-exercise or peak exercise values are indicated by the § symbol. 
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Figure 3.5: The relationship between mean velocity of circumferential fiber shortening 
(MVCFc) and stress at peak systole (σPS) at pre- and peak exercise for patients with 
anorexia nervosa (AN) and controls. The error bars indicate the standard error of the 
mean. 
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Figure 3.6: Response of (A.) systemic vascular resistance indexed (SVRI) and (B.) total 
arterial compliance indexed (TACI) to progressive exercise in patients with anorexia 
nervosa (AN) and controls. The error bars indicate the standard error of the mean. Stage 0 
is the pre-exercise stage, with each incremental increase in stage number representing a 
20 Watt increase in workload. Box plots comparing  the mean values for (C.) SVRI and 
(D.) TACI at pre- and peak exercise for the AN and control groups are provided. 
Significant differences (p<0.05) between values at pre-exercise and peak exercise for 
either the AN or control groups are indicated by the * symbol. Significant differences 
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(p<0.05) between the control and AN groups for either pre-exercise or peak exercise 
values are indicated by the § symbol. 
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Chapter 5: Summary 
 
 To our knowledge, this study presents the largest comprehensive assessment of 
cardiovascular health in adolescent females with AN. We found that in a large cohort of 
95 female adolescents with AN, there was a reduction in cardiac dimensions with a 
decrease in LA and LV size. Wall thickness and LVM were decreased in the patient 
group, with the decrease in wall mass being out of proportion to the decrease in body size. 
On all measures of systolic function performed, there were no differences at rest between 
the patient group and controls. However, patients with AN demonstrated decreases in 
diastolic tissue Doppler measurements, which are a measure diastolic ventricular 
function. These results suggest that although there is a downregulation in the size and 
thickness of the heart in adolescent patients with AN as well as subclinical abnormalities 
of diastolic function, systolic function at rest is preserved.  
 In order to determine if abnormalities in ventricular function could be unmasked 
during times of hemodynamic stress, we investigated ventricular function during 
progressive exercise in patients with AN as compared to controls. We found that the 
patients with AN had decreased exercise capacity and decreased measures of systolic 
function at peak exercise, although their cardiac responses and ventricular function with 
progressive exercise were similar to that of controls. Our results suggest that the 
decreased exercise capacity in this patient population was unlikely to be caused by 
cardiac systolic dysfunction due to the normal pattern of cardiac response to progressive 
exercise. However, we were unable to examine diastolic function during exercise and 
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cannot exclude the possibility of diastolic function worsening with exercise in this patient 
population.  
Normal function of the cardiac system is dependent of the integrity of the vascular 
system. In addition, abnormal vascular stiffness is a risk factor for future cardiovascular 
events. Thus, we endeavoured to determine the biophysical properties of the aorta as a 
measure of vascular function in patients with AN due to the close interrelation between 
the heart and the vasculature. We found that patients with AN had elevated PWV of the 
aorta, indicating increased aortic stiffness in this patient population. This result suggests 
that patients with AN may be at risk for increased future cardiovascular events, although 
we do not know if the increased vascular stiffness is reversible with nutritional 
rehabilitation.  
Our study also investigated the effect of degree of malnutrition, as measured by BMI 
percentile, on the various measures of cardiovascular function. The most malnourished 
patients, which we defined as those with a BMI less than or equal to the 10th percentile, 
showed decreased LA and LV size, decreased LVM, and changes in diastolic function, 
while the patients with a lesser degree of malnutrition did not demonstrate these changes. 
Exercise endurance was independently predicted by BMI percentile. In contrast, increased 
arterial stiffness was not related to the degree of patient malnutrition. These results 
suggest that it is the most malnourished adolescent patients with AN that are likely to 
demonstrate changes in cardiac structure and diastolic function, however, increased 
vascular stiffness in AN cannot be predicted by the severity of malnutrition.  In 
summary, our study demonstrates that patients with AN have abnormalities of their 
cardiovascular system including decreased cardiac size, decreased cardiac mass, 
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subclinical diastolic dysfunction, and increased aortic stiffness.  Systolic function remains 
preserved in this patient population both at rest and with progressive exercise. Further 
study is required in order to determine if these changes are reversible with weight gain, 
particularly the changes in diastolic function and aortic stiffness.  
 
 
Significance of the Study: 
 To our knowledge, this study represents the largest published comprehensive 
assessment of cardiovascular health in adolescent females with AN. Individually, the 
manuscripts in Chapters 2-4 investigate novel measures of cardiovascular structure and 
function and are amongst the largest studies of their kind in adolescents with AN.  
Chapter 2 is one of the largest studies investigating cardiac structure and function 
in adolescent females with AN. This study confirms the findings of previous studies 
demonstrating decreased cardiac dimensions, decreased wall thickness, decreased LV 
mass, and similar systolic function in patients with AN compared to controls [1-4]. This is 
also the largest study investigating tissue Doppler in patients with AN. However, our 
tissue Doppler findings contrast those reported by Galetta et al. (2005) and bear repeating 
prior to drawing conclusions regarding the diastolic function in patients with AN [5]. Our 
study is also one of the first studies to use BMI percentile to suggest that the identified 
cardiac changes occur in the most malnourished patients (BMI ≤ 10th percentile) with few 
substantial differences in cardiac parameters in less malnourished patients (BMI > 10th 
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percentile). These finding suggest that the most malnourished patients are at higher risk of 
cardiac changes, which may have implications for follow-up protocols for these patients.  
Chapter 3 investigates a novel topic in adolescent females with AN as, to our 
knowledge, arterial stiffness has not been previously evaluated in this patient population. 
In addition, Chapter 3 contributes to the literature supporting the premise that these 
patients demonstrate abnormalities in markers associated with cardiovascular risk [6-16] 
which may have implications for follow-up of these patients.  
The role of excessive exercise in producing weight loss in AN is well documented 
while the role of exercise as part of therapy for AN is new and its safety is controversial 
[17-21]. Chapter 4 is the largest study investigating exercise function in patients with AN 
as well as the largest study investigating echocardiographic systolic ventricular function 
with progressive exercise in this patient population. This study supports the findings of 
subnormal exercise tolerance, decreased VO2, blunted HR response, and decreased BP 
response at peak exercise in patients with AN [3, 22-28]. Chapter 4 also represents one of 
the only studies that demonstrates that although the parameters of cardiac function at peak 
exercise are different from those of controls, adolescents with AN have normal cardiac 
responses to progressive exercise. Our findings suggest that it was safe to exercise under 
the conditions of testing and is encouraging, but care should be taken in expanding this to 
all forms of supervised or unsupervised exercise.  
 
Limitations 
The studies performed were single-center retrospective case-control studies. This 
study design has several potential limitations. One limitation is the possibility of 
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misclassification/information bias. The classification of patients as having AN, as 
opposed to an alternative eating disorder, as well as the subtype of AN (AN-R vs AN-BP) 
was based on chart review and, therefore, there is the potential that patients were 
misclassified due to inadequate or inaccurate information contained in the medical record. 
Several potentially important baseline parameters were also not universally available in 
the patient records including prior level of physical activity and duration of illness prior to 
presentation. There was also potential for selection bias as this study was performed at a 
tertiary care center, which may have led to our studies investigating a more severely 
affected cohort of patients with AN which is not representative of the general adolescent 
female AN population. Due to the retrospective design, we were not able to control for 
the timing of the resting or exercise echocardiograms and these tests were performed at 
variable times in the disease course and at variable stages of nutritional rehabilitation. 
 
Future Directions: 
Our study demonstrated statistically significant differences in several measured 
variables; however the clinical significance of these findings is unclear at present. It is 
possible that the demonstrated differences in patients with AN may remain subclinical 
and  have little impact on their clinical course, however, the potential for clinical impact 
cannot be ruled out in the absence of long term surveillance. The findings of our studies 
demonstrate that patients who are the most malnourished (BMI < 10th percentile) 
demonstrate changes in their cardiac dimensions and diastolic function, which suggests 
that these patients warrant more careful monitoring. However, several factors remain 
unknown including the BMI percentile cutoff associated with cardiac changes, if clinical 
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variables other than BMI percentile are important for determining the risk of cardiac 
changes, and the clinical implications of these changes. The findings of our study also 
suggest that patients with AN may be at risk of future cardiovascular disease and may 
warrant long term monitoring for the possible development of premature cardiovascular 
disease. However, the reversibility of the increased aortic stiffness, the subset of patients 
at highest risk for this potential complication, the factors which worsen or lessen this risk, 
and the long-term clinical implication of increased aortic stiffness in the AN population 
are unknown. Further studies to answer these clinical questions are required. Long term 
studies investigating cardiac function and aortic stiffness with serial assessments in larger 
cohorts of patients and controls would be valuable. Such studies could potentially help 
answer the questions posed above, determine the impact of disease severity and duration 
on the cardiovascular system, as well as determine the long term impact of these changes 
on cardiovascular health and outcomes.  
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Appendix  
Appendix 1: Tabular summary of results of echocardiography in the published literature comparing females with anorexia 
nervosa to control groups 
 de Simone 
et al. 
(1994) 
Romano et 
al. (2003)   
Vazquez et 
al. (2003) 
Eidem et 
al. (2001) 
Galetta et 
al. (2003) 
Galetta et 
al. (2005) 
Kastner et 
al. (2012) 
St John 
Sutton et 
al. (1985) 
Number of 
subjects 
21 91 30 13 25 20 173 17 
Mean/ median 
subject age 
(years) 
22  20.5  15.5  16.5 17.5 22.4 15.3 26 
Mean BMI 15.2 15.6  15.3 - 15.3 15.0 14.5 - 
Control groups Normal 
BMI and 
thin 
females 
Normal 
weight 
Normal 
weight age-
matched 
Normal 
weight age, 
gender, and 
heart rate 
matched 
Normal 
BMI and 
thin 
females 
Normal 
BMI and 
thin 
females 
Normal 
weight 
Normal 
weight 
Hemodynamic parameters 
Heart rate 
(bpm) 
Decreased 
(59 vs 
73/76) 
Decreased 
(55.6 vs 
72.4) 
Decreased 
(56.9 vs 
82.9) 
No 
difference 
(matched) 
Decreased 
(50.6 vs 
70.3/68.7) 
Decreased 
(45.7 vs 
63.7/64.2)  
 
- 
No 
difference 
Systolic BP 
(mmHg) 
Decreased 
(101 vs 
118/109) 
Decreased 
(90.8 vs 
110.9) 
 
- 
 
- 
Decreased 
(92.4 vs 
117.3/ 
112.6) 
Decreased 
(98.8 vs 
111.4/ 
108.2) 
 
- 
Decreased 
(93 vs 110) 
Diastolic BP Decreased Decreased   Decreased Decreased  Decreased 
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(mmHg) (66 vs 
78/72) 
(62.1 vs 
70.3) 
- - (50.6 vs 
68.5/66.4) 
55.2 vs 
65.6/64.7) 
- (65 vs 74) 
Cardiac Chamber Dimensions 
LA size (cm) Decreased 
(2.55 vs 
3.09) 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
LVEDD (cm) Decreased 
(3.96 vs 
4.72/4.41) 
Decreased 
(4.26 vs 
4.57) 
Decreased 
(4.19 vs 
4.49) 
 
- 
Decreased 
(4.08 vs 
4.49/4.48) 
Decreased 
(3.9 vs 
4.5/4.4) 
Decreased 
(4.1 vs 4.7) 
Decreased 
(3.9 vs 4.4) 
LVESD (cm)  
- 
 
- 
Decreased 
(2.53 vs 
2.78) 
 
- 
Decreased 
(2.14 vs 
2.88/2.81) 
 
- 
Decreased 
(2.5 vs 2.9) 
Decreased 
(2.6 vs 2.9) 
IVSD (mm)  
- 
 
- 
Decreased 
(6.1 vs 6.9) 
 
- 
No 
difference 
Decreased 
(6.5 vs 
8.0/7.9) 
No 
difference 
 
- 
LVPWD (mm)  
- 
 
- 
No 
difference 
 
- 
No 
difference 
Decreased 
(5.9 vs 
7.5/7.5) 
No 
difference 
Decreased 
(0.6 vs 0.7) 
LV mass (g) Decreased 
(73.3 vs 
124/103) 
Decreased 
(71.2 vs 
96.9) 
Decreased 
(76.2 vs 
98.3) 
Decreased 
(79.4 vs 
106) 
Decreased 
(82.7 vs 
126.1/ 
119.5) 
Decreased 
(66.2 vs 
109.5/ 
106.8) 
 
- 
 
- 
LV mass/BSA 
(g/m2) 
Decreased 
(54.9 vs 
75.2/66.9) 
Decreased 
(52.2 vs 
61.3) 
Decreased 
(53.9 vs 
64.0) 
 
- 
 
- 
 
- 
 
- 
Decreased 
(53 vs 79) 
LV mass/height 
(g/m2.7) 
Decreased 
(21.1 vs 
33.2/26.5) 
Decreased 
(20 vs 26) 
 
- 
 
- 
Decreased 
(21.2 vs 
31.4/29.2) 
Decreased 
(20.3 vs 
30.1/29.5) 
 
- 
 
- 
Relative wall 
thickness 
No 
difference 
- - - - - - No 
difference 
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Measures of Cardiac Function 
Fractional 
shortening 
No 
difference  
- No 
difference 
- No 
difference 
No 
difference 
No 
difference 
No 
difference 
Ejection 
fraction 
 
- 
Decreased 
(62.7 vs 
65.03) 
No 
difference 
No 
difference 
No 
difference 
No 
difference 
 
- 
No 
difference 
Peak E velocity 
(m/s) 
No 
difference 
- - - No 
difference 
No 
difference 
- - 
Peak A velocity 
(m/s) 
Decreased 
(0.43 vs 
0.56/0.52) 
 
- 
 
- 
 
- 
Decreased 
(0.359 vs 
0.466/ 
0.452) 
Decreased 
(0.337 vs 
0.453/ 
0.443) 
 
- 
 
- 
Peak E/A ratio Increased 
(1.96 vs 
1.52/1.51) 
 
- 
 
- 
No 
difference 
Increased 
(2.8 vs 
1.9/1.8) 
Increased  
(2.8 vs 
1.95/1.96) 
 
- 
 
- 
Mitral inflow 
deceleration 
time 
 
- 
 
- 
 
- 
No 
difference 
No 
difference 
 
- 
 
- 
 
- 
LV MPI  
- 
 
- 
 
- 
Increased 
(0.49 vs 
0.35) 
 
- 
 
- 
 
- 
 
- 
RV MPI - - - No 
difference 
- - - - 
IVRT - - - - No 
difference 
- - - 
End systolic 
stress (dyn/cm2) 
No 
difference 
- - - - - - No 
difference 
Velocity of 
circumferential 
fiber shortening 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
No 
difference 
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Echocardiographic Hemodynamic Variables 
Cardiac output 
(L/min) 
Decreased 
(2.69 vs 
5.57/4.39) 
Decreased 
(2.8 vs 4.5) 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
Cardiac index 
(L/min/m2) 
Decreased 
(2.01 vs 
3.4/2.87) 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
Stroke volume 
(ml/beat) 
Decreased 
(46.2 vs 
77.6/58.4) 
Decreased 
(50.7 vs 
62.1) 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
Stroke index 
(ml/beat/m2) 
Decreased 
(29.1 vs 
47.7/35.3) 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
SVR  
(dyn•s•cm-5) 
Increased 
(2791 vs 
1527/1636) 
Increased 
(2191 vs 
1590) 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
Tissue Doppler 
S’ lateral - - - - - Decreased - - 
S’ septal - - - - - Decreased - - 
E’ lateral - - - - - No 
difference 
- - 
E’ septal - - - - - No 
difference 
- - 
A’ lateral - - - - - No 
difference 
- - 
A’ septal - - - - - No 
difference 
- - 
E/E’ lateral - - - - - Increased - - 
E/E’ septal - - - - - Increased - - 
E’/A’ lateral - - - - - No - - 
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difference 
E’/A’ septal - - - - - No 
difference 
- - 
Other 
MV abnormal 
motion (% of 
subjects) 
Increased 
(62 vs 5/9) 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
BMI = body mass index, bpm = beats per minute, BP = blood pressure, LA = left atrial, LVEDD = left ventricular end-diastolic 
diameter, LVESD = left ventricular end-systolic diameter, IVSD = interventicular septal diameter, LVPWD = left ventricular 
posterior wall diameter, LV = left ventricular, BSA = body surface area, MPI = myocardial performance index, RV = right 
ventricular, IVRT = isovolumic relaxation time, SVR = systemic vascular resistance, MV = mitral valve 
 
